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ABSTRACT OF DISSERTATION 
 
 
 
 
ROLE OF P33 IN TOMBUSVIRUS REPLICATION 
 
Replication of the nonsegmented, plus-stranded RNA genome of Cucumber necrosis 
tombusvirus (CNV) requires two essential overlapping viral-coded replication 
proteins, the p33 replication co-factor and the p92 RNA-dependent RNA polymerase. 
In my thesis I describe (i) the effect of phosphorylation of p33, (ii) the RNA 
chaperone-like activity of p33, and (iii) the role of  HSP70s a host proteins in the viral 
replication. To test the effect of phosphorylation on p33 function, I used in vitro 
phosphorylated p33. I found that phosphorylation inhibited the ability of p33 to bind 
to the viral RNA. Phosphorylation-mimicking mutations rendered p33 nonfunctional 
in plant protoplasts and in yeast.  
Based on these results, I propose that the primary function of phosphorylation of p33 
is to regulate its RNA binding capacity, which could affect the assembly of new viral 
replicase complexes, recruitment of the viral RNA template into replication and/or 
release of viral RNA from replication. Thus, phosphorylation of p33 might help in 
switching the role of the viral RNA from replication to other processes, such as viral 
RNA encapsidation and cell-to-cell movement. Small plus-stranded RNA viruses do 
not code for RNA helicases that would facilitate the proper folding of viral RNAs 
during replication. Instead, small RNA viruses might use RNA chaperones for 
replication as shown here for the p33 replication protein. In vitro experiments 
demonstrated that the purified recombinant p33 facilitated RNA synthesis on plus-
stranded and double-stranded (ds)RNA templates up to 5-fold. In addition, p33 
rendered dsRNA templates sensitive to single-strand specific S1 nuclease, suggesting 
that p33 can destabilize highly structured RNA. Altogether, the RNA chaperone 
activity of p33 might perform similar biological functions to the helicases. SSa a 
yeast HSP70 found in the viral replication complex and shown to facilitate viral 
replication (Serva and Nagy, 2006)To dissect the mode of action of SSA in the viral 
replication I used temperature sensitive and deletion mutants.  Both showed miss 
localization of p33 compared to the wild type.  Purified SSA rendered non functional 
bacterial expressed p92 functional in an  in vitro replication assay. SSa might play a 
role in the transportation and assembly of viral replication proteins.  
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CHAPTER I 
 
General introduction 
 
 Positive stranded RNA plant viruses  
 
Plant viruses are intracellular pathogens. During their life cycle they replicate 
and encapsidate inside the infected plant cell.  The majority of plant viruses are 
positive stranded RNA viruses. The life cycle of positive stranded RNA consists of 
entering the plant cell, disassembly (removal of the capsid proteins that leads to 
exposure of the viral RNA to the ribosomes), translation of the viral RDRP (RNA 
dependent RNA polymerase) and auxiliary replication proteins from the viral 
genomic RNA, genome replication and transcription using the genomic RNA as a 
template, encapsidation of the newly transcribed RNA , and cell-to-cell movement. 
Plant RNA viruses, however, have small genomes encoding only a few (4-10) 
proteins.   To complete the multiple tasks during the infection cycle they utilize not 
only the viral-coded proteins but co-opt host encoded proteins as well, 
reprogramming the infected cell into, a virus producing mode.  
The key event in a positive strand RNA infection cycle is genome replication. 
Since the  positive strand RNA viruses use a unique enzyme for their replication 
(RNA dependent RNA polymerase), this unique event is a good a target for future 
antiviral drogs. During the replication a  (+) RNA virus uses its RNA for recruiting 
the replicase complex  (RC), which consists of viral and host proteins (Pogany et al., 
2005). The viral RNA contains cis-acting regulatory regions to control the replication 
process and subgenomic RNA synthesis  (Pogany et al., 2003). The replication of the 
(+)  RNA viruses is an asymmetric process that produces the positive (mRNA sense) 
strand progeny in 20-100 excess over the negative sense RNA (Nagy, 2008). The 
viral replication complexes utilize different subcellular membranes as “platforms” for 
replication, including endoplasmatic reticulum, mitochondria, vacuoles, Golgi, 
chloroplasts, and peroxisomal membranes (Salonen et al., 2004). 
During the course of my PhD work, I focused my research on positive strand (+) plant 
viral replication using the intensively-studied tombusviruses as model viruses. 
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Tombusviruses 
 
Tombusviruses are emerging plant pathogens that are among the best 
characterized plant viruses (White and Nagy, 2004). Tombusviruses, such as Tomato 
bushy stunt virus (TBSV) and Cucumber necrosis virus (CNV), have monopartite, 4.8 
kb long single-stranded RNA genomes with mRNA-sense polarity. They belong to 
supergroup 2 viruses that include important plant pathogens (luteoviruses, 
carmoviruses, and others), human and animal pathogens (hepatitis C virus, 
flaviviruses, pestiviruses), and bacteriophages (Qbeta). Tombusviruses have a 
nonsegmented genomic RNA with five open reading frames (ORF), two of which 
code for essential replication proteins, termed p33 and p92. P33 and p92 were shown 
to be essential for tombusvirus replication (Oster et al., 1998) and recombination 
(Panaviene and Nagy, 2003). Both p33 and p92 are directly translated from the 
genomic RNA and p92 is the result of translational readthrough of the translation stop 
codon at the end of the p33 ORF. Due to the protein expression strategy of 
tombusviruses, the N-terminal portion of p92 overlaps with p33 (Scholthof et al., 
1995). p 92 contains the signature RdRp motifs and together with p33 is part of the 
tombusvirus replicase (Scholthof et al., 1995). The auxiliary p33 is a replication co-
factor that plays a role in template selection (Pogany et al., 2005)and viral RNA 
recruitment into replication (Monkewich et al., 2005; Panavas and Nagy, 2005) via 
selectively binding to a conserved stem-loop element [RII-SL(+), a high-affinity 
binding sequence for p33, termed p33 recognition element, or p33RE] present within 
the p92 ORF. P33 binds to the viral RNA via its arginine–proline-rich (RPR) domain, 
which was shown to be essential for tombusvirus replication (Panaviene et al., 2003; 
Rajendran and Nagy, 2003), and it also affects subgenomic RNA synthesis and RNA 
recombination (Panaviene and Nagy, 2003). Together, with the viral RNA, p33 is 
required for the assembly of the functional replicase complex (Panaviene et al., 2004; 
Panaviene et al., 2005), which also contains the p92 RNA-dependent RNA 
polymerase and possibly host factors. In addition to protein: RNA interactions, the 
assembly of the replicase might be aided by interactions between p33 and other p33 
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and p92 molecules, which are essential for replication (Rajendran and Nagy, 2004). 
Altogether, p33 is likely involved in many essential replication functions, such as 
template RNA binding (Monkewich et al., 2005; Panavas and Nagy, 2005; Pogany et 
al., 2005), assembly/disassembly of the viral replicase complex (Panaviene et al., 
2004; Panaviene et al., 2005), targeting and/or attaching the replicase complexes to 
subcellular membranes (Navarro et al., 2004; Panavas and Nagy, 2005), 
complementary RNA synthesis, release of the newly made viral RNA progeny from 
the site of replication, and so on. P33 seems to be a multifunctional protein affecting 
viral RNA replication and possibly other processes (Burgyan et al., 2000). 
 
Posttranslational modifications of viral proteins 
 
 
Posttranslational modification of proteins affects the functions and stability of 
many cellular proteins, such as those involved in the control of gene expression, 
signal transduction and cell cycle regulation. The most common posttranslational 
modification is reversible phosphorylation/dephosphorylation, which could serve as a 
switch between active and inactive forms of proteins (Hunter and Karin, 1992). For 
example, an important cellular antiviral defense system depends on dsRNA-triggered 
phosphorylation/activation of PKR, which then leads to phosphorylation of eIF2alpha 
and inhibition of translation (Gunnery and Mathews, 1998). The Tat protein of 
Human immunodeficiency virus-1 (HIV) is known to inhibit PKR activity by 
competing with eIF2 for phosphorylation by the activated PKR. The interaction 
between Tat and PKR requires the RNA binding region of Tat (Brand et al., 1997; 
Gunnery and Mathews, 1998). Phosphorylation of serine/threonine residues is also 
known to regulate the formation of protein complexes (Pawson and Scott, 1997), and 
it can also be used as a signal to trigger ubiquitination and degradation of proteins 
(King et al., 1996). Phosphorylation of viral proteins is also common. Example 
include regulation of function of the viral movement proteins (MP) in plants 
(Sokolova et al., 1997; Karpova et al., 1999; Waigmann et al., 2000; Trutnyeva et al., 
2005). The phosphorylated MP binds to the viral RNA less efficiently than the 
nonphosphorylated form, which might be important in facilitating the release of the 
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bound RNA from the MP:RNA complex during cell-to-cell movement of viral RNAs 
(Waigmann et al., 2000; Lee and Lucas, 2001). Binding of coat protein to viral RNA 
is also inhibited by phosphorylation (Kann et al., 1999; Ivanov et al., 2001; Ivanov et 
al., 2003). Protein phosphorylation can also regulate the intracellular distribution of 
viral proteins (Kann and Gerlich, 1994). Another role of phosphorylation 
/dephosphorylation is to regulate virus replication. For example, protein: RNA 
interaction and replicase assembly of animal negative-strand RNA viruses are 
controlled by phosphorylation (Barik and Banerjee, 1992; Takacs et al., 1992; Gao 
and Lenard, 1995; Gao et al., 1996; Lenard, 1999). Rapid formation of an RNA 
binding site in the HIV Rev protein is promoted by phosphorylation of serine residues 
(Fouts et al., 1997). Similarly, phosphorylation of Rex protein of human T-cell 
leukemia virus (HTLV) alters the conformation of Rex and its ability to bind to viral 
RNA, which serves as a switch between the latent and productive phases of the 
HTLV infection cycle (Narayan et al., 2001; Younis and Green, 2005). 
Phosphorylation of replication proteins of animal and plant viruses has also been 
documented, which could regulate interaction between the replication proteins 
(Hericourt et al., 2000; Kim et al., 2002; Puustinen et al., 2002; Evans et al., 2004; 
Street et al., 2004). However, the role of phosphorylation /dephosphorylation of 
replication proteins in plus-strand RNA virus replication is currently poorly 
understood. 
 
RNA chaperones in viral replication 
 
RNA viruses utilize their genomes not only as templates to produce more viral 
RNA progeny during replication, but for many other processes, such as translation, 
regulation of replication, encapsidation and movement from cell to cell. The folding 
of viral RNAs in biologically relevant conformation is important because the RNA 
can be trapped in one of many incorrect structures. Therefore, RNA binding proteins, 
such as helicases and cofactors, have been proposed to play auxiliary roles in most 
steps during the viral infection process. However, unlike larger RNA viruses, small 
plus-strand (+)RNA viruses with genomes less than 6,000 nt do not code for RNA 
helicases (Koonin and Dolja, 1993). This suggest that these small RNA viruses might 
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not need helicases with robust unwinding functions for their replication or, 
alternatively, they might recruit RNA helicases(s) from the host. Another alternative 
possibility is that these RNA viruses might code for RNA chaperones, which are also 
capable of unwinding/destabilizing RNA structures (Cristofari and Darlix, 2002).  
 
Role of host factors  in viral replication 
 
During the genome wide screen of yeast genes (Panavas 2005) a number of 
host factors were identified that alter viral replication. Recent studies deciphered the 
mechanism how these proteins affect the replication of positive strand RNA viruses.  
Cdc34p ubiquitin-conjugating enzyme was identified as a component of the 
tombusvirus replicase complex and shown to ubiquitinate p33 replication protein (Li 
et al., 2008). Downregulation of the cdc34p level decreases the DI-72 accumulation 
in the yeast based viral replication system, and decreases the activity of the viral 
replicase purified from the yeast cells with downregulated level of cdc34p expression. 
The in vitro and in vivo assays demonstrated that cdc34p plays a crucial role in 
tombusvirus replication.  
Tdh2p was shown to co-purify with the viral replicase complex from yeast 
(Serva and Nagy, 2006). A more recent publication reveals the role Tdh2p plays in 
tombusvirus replication (Wang and Nagy, 2008). The lack of the tdh proteins in the 
mutated yeast strain resulted in equal amount of + and – strand accumulation, 
suggesting that Tdh proteins promote + strand synthesis  by selectively binding the 
negative strand  replicon RNA and retaining it in the replicase complex. 
In my studies I continued Dr Serva’s work who identified HSP70 proteins 
(Ssa1/2p) in the viral replication complex and showed that downregulation of Ssa1/2p 
levels inhibited while upregulation of Ssa2p level facilitated viral replication (Serva 
and Nagy, 2006). 
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Goals and hypothesizes 
 
The main objective of my research was identifying the role(s) p33 plays in 
tombusvirus replication. The close focus of my research was to understand the 
mechanism of the multiple roles of p33 in the viral replication process.  
During my study two powerful tools were used extensively, the defective interfering 
RNA and the yeast replication system.  
 
DI RNA a robust replicon 
 
Tombusviruses are often associated with defective interfering (DI) RNAs 
(Havelda et al., 1995). The DI RNAs are often called “superparasites” because for 
their replication they completely rely on the viral replication machinery. They do not 
encode any functional genes. DI RNAs were discovered by their amelioration of the 
viral symptoms (Hillman et al., 1987).  
A typical DI RNA, such as DI-72, consists of four noncontiguous RNA 
regions derived from the viral genome. These regions are essential for viral RNA 
replication. Due to the short length and lack of translation, DI RNAs are better 
templates for replication than the genomic RNA. DI-72 RNA competes for the 
replication machinery with the genomic and subgenomic RNA which leads to 
symptom attenuation and DI RNA accumulation (Hillman et al., 1987). These 
features make the DI-72 an excellent tool as a surrogate template to study 
tombusvirus replication.   
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Yeast as a model host to study viral replication 
 
In recent studies, yeast has emerged as a powerful tool to study viral 
replication. Viral replication systems were established in yeast with plant viruses: 
Brome mosaic virus (Janda and Ahlquist, 1993), geminivirus  (Raghavan et al., 
2004), and with animal viruses (Naito et al., 2007),showing that several viruses can 
replicate in yeast cells. Dr Panavas in our lab established a novel yeast system 
(Panavas and Nagy, 2003) capable of supporting the replication of DI-72 replicon 
RNA when CNV p33 and P92 replication proteins were co-expressed.  
The relatively small genome of the yeast (Saccharomyces cerevisiae) made it 
easier to perform genome wide screens identifying host genes which play a role in 
viral replication. The availability of a single gene deletion library (Yeast Knock Out), 
two hybrid libraries and, a commercially available yeast overexpression library makes 
yeast an ideal host to study viral replication (Nagy, 2008). 
My studies were evolving around p33 including three major areas,  
phosphorylation of p33 and its effect on viral replication, the RNA chaperone activity 
of p33 and the role of a host hsp 70 in viral replication. 
 
Phosphorylation of p33 and its effect on viral replication 
 
The objectives of the phosphorylation study was to show the phosphorylation 
of p33 at a predicted phosphorylation site in the vicinity of the RNA binding motif, 
and test the effect of the phosphorylation on the tombusvirus replication. 
My hypothesis was that either the 211 S or\and 210 T residue can be 
phosphorylated, and the negative charge introduced by the phosphorylation interferes 
with the RNA binding of the p33. 
To test my hypothesis first I showed the phosphorylation of p33 in vivo by 
immunoprecipitating the protein from CNV infected N. bentamiana leaves and 
immunoblotted the p33 with antibodies raised against phosphorylated threonine. To 
show the phosphorylation of a conserved 210-211 site I developed an in vitro 
phosphorylation system using N. benthamiana leaf extract as a kinase source and a 60 
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amino-acid long portion of p33 which contains the phosphorylation sites and the 
RNA binding domain.   
 After showing the phosphorylation of the conserved 210 S  211 T sites, we 
mutated the phosphorylation sites and examined the effects of the 
phosphorylation\unphosphorylation mimicking pointmutantions on viral RNA 
accumulation in infected plants and protplasts In collaboration with Natalia Shapka. I 
used the same mutations to test the second part of the hypothesys. Using gel mobility 
assays I demonstrated that the phosphorylated form of p33 binds significantly lower 
amount of viral RNA. 
 
RNA chaperone activity of p33 
 
The objective of the chaperone project was to test the RNA chaperone activity 
of p33. Our hypothesis was that tombusviruses don’t use host helicases and\or host 
RNA chaperones to complete the unwinding an RNA folding processes which can 
occour during replication because the p33 can act as an RNA chaperone and complete 
the RNA folding\unwinding tasks needed for replication. 
To test this hypothesis I tested the chaperone activity of p33 with by testing 
the annealing\unwinding capability of the protein on short (15-17 nucleotide) 
complementary RNA strands. RNA chaperones facilitate unwinding in high 
concentrations and annealing in low concentrations. My results showed very weak 
chaperone activity. I used the other published general RNA chaperone test, whether 
p33 inteferes with the shelf cleaving activity of a ribozyme. Again my results showed 
really weak interference.   
To show unwinding facilitated by p33 I used s1 nuclease. When I added s1 
nuclease to the unwinding reaction, it digested the unwound single stranded RNA 
freeing up p33 to unwind another double stranded RNA molecule. Finally I used 
double stranded RNA as a template in an in vitro RDRP reaction while adding p33 in 
an increasing concentration, and showed that p33 facilitates the initiation of p88c 
(TCV RDRP) on double stranded templates. 
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Role of a host HSP 70 in viral replication 
 
The objective of this study was to show the role of a host HSP 70 (Ssa) in 
viral replication. My hypothesis was that Ssa facilitates the transportation and 
membrane insertion of p33 and p92.   
To test the hypothesis I used temperature sensitive mutant Ssa p and in 
collaboration with Dr Robert Wang we showed that p33 localizes in the cytosol 
without the Ssa function. The membrane insertion was shown by western blott 
analysis of the yeast membrane fraction in the presence and in the absence of Ssa. 
While experimenting with the membrane insertion of p33 I was able activate the 
recombinant p33 p92- MBP proteins expressed in E. coli, which were inactive 
without the Ssa function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright  2009 ELSEVIER 
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CHAPTER II 
 
 
Phosphorylation of the p33 replication protein of Cucumber necrosis tombusvirus 
adjacent to the RNA binding site affects viral RNA replication 
 
Introduction 
 
Replication of plus-strand RNA viruses, which are the most abundant among 
plant, animal, and human viruses, is performed by viral replicases (Buck, 1996; 
Ahlquist, 2002; Ahlquist et al., 2003). The viral replicase consists of viral proteins, 
including the RNA-dependent RNA polymerase (RdRp), and putative host factors. In 
spite of their significance in virus replication, our current understanding of the roles 
of viral and host proteins is incomplete. These proteins are likely subject to 
posttranslational modification(s), which could affect/regulate their functions in viral 
replication. Indeed, reversible phosphorylation and other posttranslational 
modifications are important for the functions of many cellular and viral proteins. For 
example, protein phosphorylation/dephosphorylation is frequently used as an “on–off 
switch”, allowing regulation of protein function.  
While considerable information is available for the role of phosphorylation of 
replication proteins in minus-strand RNA viruses, which code for P replication 
protein, a phosphoprotein (Barik and Banerjee, 1992; Takacs et al., 1992; Lenard, 
1999), the role and significance of phosphorylation of replication proteins in plus-
strand RNA viruses are currently poorly understood. The examples include 
phosphorylation and ubiquitinylation of Turnip yellow mosaic virus RNA-dependent 
RNA polymerase (RdRp) (Hericourt et al., 2000) and the Vpg of potyviruses 
(Puustinen et al., 2002). Also, phosphorylation of CMV 2a RdRp protein was shown 
to occur late in infection, affecting its interaction with the 1a replication protein (a 
methyltransferase and helicase-like protein) (Kim et al., 2002). Phosphorylation of 
the NS5A replication protein of hepatitis C virus (HCV) has been indicated to affect 
HCV replication and cellular signaling, likely facilitating establishment of chronic 
infections (Huang et al., 2004; Macdonald et al., 2004; Street et al., 2004). 
Phosphorylation of the NS5B RdRp protein of HCV has been proposed to play 
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critical role in HCV replication, based on enhanced HCV replication in cells 
overexpressing protein kinase C-related kinase 2 (PRK2, a host kinase), which is 
known to interact with NS5B (Kim et al., 2004)In addition to the proposed role of 
phosphorylation in virus replication, posttranslational modification also affects the 
functions of other viral proteins, as demonstrated for movement (MP) and coat 
proteins (CP) of plus-stranded RNA viruses of plants (Waigmann et al., 2000; Ivanov 
et al., 2003). 
Because posttranscriptional modifications of the replication proteins might 
play roles as molecular switches in the replication process by altering the properties 
of the replication proteins, we tested if the tombusvirus p33 is phosphorylated in 
infected plants. This study establishes that phosphorylation of the p33 replication 
protein takes place both in vivo and in vitro. Using kinase-containing plant extract, 
the phosphorylation sites were mapped to threonine/serine (T/S) residues located in 
the vicinity of the RNA-binding site, suggesting the possible role of phosphorylation 
in modulating the RNA-binding activity of p33. Using phosphorylation-mimicking 
aspartic acid (D) mutants of p33, we demonstrate that phosphorylation of the T/S 
residues in p33 could influence subgenomic versus genomic RNA synthesis and the 
ratio between plus- and minus-stranded RNAs. Phosphorylation incompetent alanine 
(A) mutants of CNV replicated slower than wild type in plant protoplast and showed 
less severe symptoms in Nicotiana benthamiana plants. In summary, our data promote 
a regulatory role for phosphorylation of p33 in tombusvirus replication. 
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Rationale 
 
Sequence comparison of p33 replication proteins of tombusviruses (Fig. 2.1A) 
revealed the presence of conserved S and T residues (i.e., T205, S210, and T211) 
adjacent to the previously identified arginine (R) and proline (P)-rich RNA-binding 
site (termed RPR-motif, R213P214R215R216R217P218) (Fig. 2.1B). These S and T 
residues are likely phosphorylated in cells based on NetPhos analysis (i.e., they 
showed the probability of 0.8–0.9 relative value on a scale of 0.0–1.0 for 
phosphorylation) (software: NetPhos, version 2.0, Technical University of Denmark) 
(Fig. 2.1B). Possible phosphorylation of these S and T residues in p33 would 
introduce negative charge in the vicinity of the positively charged RPR-motif, thus 
likely decreasing the RNA-binding capacity of p33. In support of this model, 
substitutions of A for arginines (R), which reduced the overall positive charge of the 
RPR motif, inhibited the ability of p33 to bind to the viral RNA as well as decreased 
tombusvirus replication in plant protoplasts (Panaviene and Nagy, 2003). Based on 
these observations, we predicted that phosphorylation of p33 adjacent to the RPR-
motif could be a regulatory “switch”, affecting its biological function(s) in 
tombusvirus-infected cells. 
The experiments in this chapter were done in collaboration with Natalja  
Shapka. 
She did the plant and protoplast experiments  (fig 2.5; 2.6; 2.7; 2.10). See enclosed 
letter from DGS. 
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Results 
 
In vivo phosphorylation of CNV p33 and the related TCV p28 replicase proteins 
 
To test if the CNV p33 and the related TCV p28 replication proteins are 
phosphorylated in plants, first I enriched p33 and p28, respectively, in our samples by 
isolating membrane-enriched fractions from CNV and TCV-infected N. benthamiana 
plants [10 days postinoculation (dpi)]. This approach is based on previous findings 
that the membrane-fraction contains the active CNV and TCV replicases (Song and 
Simon, 1994; Nagy and Pogany, 2000) and the viral replication proteins (Fig. 2.2A 
(Panaviene et al., 2004). The obtained fractions were treated with SDS, followed by 
SDS-PAGE electrophoresis and blotting on PVDF membranes for Western blot 
analysis. I used antibody specifically recognizing either phosphorylated T or S 
residues for the Western blot assays (Kim et al., 2004). Data obtained with the anti-
phosphothreonine antibody (Fig. 2.2B) showed that membrane-enriched fraction from 
CNV and TCV-infected plants contained phosphorylated T residues in p33 and p28, 
whereas healthy plants lacked similar proteins. In contrast, the anti-phosphoserine 
antibody-based assay was not sensitive enough to detect phosphorylated p33 and p28 
(not shown). In addition, we also captured p33 with anti-p33 antibody from CNV-
infected plants (using isolated membrane-enriched fraction, which was treated with 
2% Triton X-100 to solubilize p33) on a protein A column, followed by elution. The 
recovered proteins were analyzed by SDS-PAGE, followed by staining with Pro-Q 
Diamond (Molecular Probes), a phosphoprotein-specific dye. This assay showed the 
presence of phosphorylated CNV p33 in plants (Fig. 2.2C). Overall, both the Western 
blot with phosphothreonine-specific antibody and the staining assay with 
phosphoprotein-specific dye demonstrated that the CNV p33 (and the related TCV 
p28) replication protein is phosphorylated at T residue(s) in infected cells. 
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In vitro phosphorylation of serine and threonine residues adjacent to the RNA-
binding domain in p33 
 
To determine if the conserved T205, S210, and T211 residues located adjacent 
to the RNA-binding site in p33 (Fig. 2.1A) can be phosphorylated, as predicted by 
NetPhos program, I developed an in vitro phosphorylation assay based on partially-
purified kinase preparation obtained from healthy N. benthamiana plants. First, I 
prepared a membrane-enriched fraction from uninfected plants using the procedure 
developed for isolation of p33 (see above) and the CNV replicase (Panaviene et al., 
2004). Then, I performed a phosphorylation assay including the kinase in the 
membrane-enriched preparation, 32P-labeled ATP, and purified peptides including or 
lacking the predicted phosphorylation sites adjacent to the RPR-motif in p33 (Fig. 
2.3). After the kinase reaction, the radioactively-labeled peptides were detected using 
SDS-PAGE/PhosphoImager analysis. This assay demonstrated that the peptide 
p33C181–240 containing the predicted T205, S210, and T211 phosphorylation sites 
could be efficiently phosphorylated in vitro by the partially-purified plant kinase (Fig. 
2.3A). The second peptide (p33C211–240), which was not phosphorylated in this 
assay, lacked T205, S210 residues and contained only T211 residue in an unfavorable 
context (Fig. 2.3A). Overall, these experiments demonstrated that healthy N. 
benthamiana plants contain a membrane-associated kinase capable of phosphorylating 
p33 in vitro at one or more of the conserved T205, S210, and T211 residues. 
Based on NetPhos analysis, the probable kinase involved in phosphorylation 
of T205, S210, and T211 residues in p33 is a protein kinase C (PKC)-like kinase. 
Interestingly, PKC-like kinase activity has been detected in plants (Sokolova et al., 
1997; Lee and Lucas, 2001)Therefore, I tested if purified PKC preparation (Sigma) 
could phosphorylate p33-derived peptides in vitro. The in vitro kinase assay revealed 
efficient phosphorylation of a 30 aa-long peptide p33C205–234 carrying wt 
sequences and less efficient phosphorylation of mutant D210, where as mutants 
A210A211 and D211 (in the context of p33C205–234) were not phosphorylated at a 
detectable level (Fig. 2.4A). Thus, these experiments demonstrated that T211 residue 
can be phosphorylated by PKC, but no data for phosphorylation of S210 residue was 
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obtained. The lack of phosphorylation of S210 residue in mutant D211 (Fig. 2.4A) 
could be due to the sequence change at position 211, because the sequence context of 
the phosphorylation site is known to affect the efficiency of phosphorylation. To 
circumvent this problem, I treated the wt p33C205–234 peptide with PKC, followed 
by detection of phosphorylated serine with anti-phosphoserine antibody (Fig. 2.4C). 
This experiment demonstrated that S210 residue could be phosphorylated by PKC in 
vitro. Therefore, we conclude that both S210 and T211 residues can be 
phosphorylated by PKC in vitro. 
 
Effect of phosphorylation of CNV p33 on virus replication based on the use of 
phosphorylation-mimicking mutants 
 
Because phosphorylation of neutral S and T residues introduces negative 
charge around these residues, effect of phosphorylation on protein function can be 
tested by mutating these residues to D, which is negatively-charged. In contrast, the 
non-phosphorylated status of S and T residues can be mimicked by mutating S and T 
residues to A, which is neutral. Thus, D mutation mimics the phosphorylated, while A 
mutation mimics the nonphosphorylated forms of S and T residues as previously 
demonstrated in numerous assays (Waigmann et al., 2000; Jabbur et al., 2001; Kim et 
al., 2002; Freye-Minks et al., 2003; Jia et al., 2004). Another advantage is that both D 
and A residues are similar in sizes to S and T residues, thus likely minimizing the 
sterical/structural changes caused by these mutations. In spite of the above 
advantages, D mutations only “mimic” phosphorylation, thus results obtained with D 
mutants could possibly cause problems unrelated to phosphorylation. 
A set of 12 single, double, and triple A/D mutations was introduced at T205, 
S210, and T211 within the p33/p92 open reading frame in an infectious cDNA clone 
of CNV (Rochon, 1991). Note that the above mutations changed the sequences of the 
overlapping p33 and p92 replication proteins (Fig. 2.1A). I then generated CNV RNA 
transcripts in vitro, followed by electroporation to N. benthamiana protoplasts to test 
the replication features of the mutated CNV proteins. Total RNA was extracted 12 
and 24 h after electroporation and analyzed by Northern blotting. These experiments 
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demonstrated that single and double D for S/T substitutions (at positions S210 and 
T211) reduced the ability of CNV to replicate to detectable levels (constructs with 
single mutations, such as D210, and D211, and double mutation, D210D211, Fig. 
2.5A). In addition, mutant D205 replicated poorly (<1% at 12, and 7% of wt at 24 h 
time points, lanes 18 and 26, Fig. 2.5A). These data suggest that negative charge(s) at 
positions S210, T211, and, to a less extent, at T205 inhibits CNV replication. 
All single and double A mutants (at T205, S210, and T211) mimicking the 
nonphosphorylated form of p33/p92 supported replication, albeit with reduced 
efficiency (34–58% of wt CNV gRNA) when compared to wt (Fig. 2.5A). Even the 
triple A mutant (construct A205A210A211, accumulation level of 13–21% of wt, 
lanes 19 and 27, Fig. 2.5A) was replication competent, suggesting that 
nonphosphorylated residues at positions 205, 210, and 211 are important for the 
function(s) of replicase proteins in vivo. However, because all these A mutants 
replicated less efficiently than wt, it is likely that phosphorylation of p33/p92 plays a 
regulatory role during virus replication (see below). 
To demonstrate that the above mutations at T205, S210, and T211 in CNV 
affected replication due to changes in the p33/p92 replication proteins, but not due to 
altered CNV RNA structure, I tested the ability of the mutated CNV replication 
proteins to support replication in trans, using a model template, DI-73 RNA (Fig. 
2.5B). Co-electroporation of DI-73 RNA with the CNV helper (wt or D210D211) into 
plant protoplasts demonstrated that CNV D210D211 did not support replication of 
DI-73 RNA in trans, indicating that the phosphorylation-mimicking replication 
protein(s) is not functional in vivo. 
To test if the above CNV mutants expressed p33 in comparable amounts, I 
performed Western blotting on total protein extracts obtained from protoplasts 12, 18, 
and 24 hpi with an antibody specific for the C-terminal portion of p33 (outside the 
mutagenized domain of p33). We found that D210D211 p33 was not detectable (Fig. 
2.5C), whereas the amount of D210A211 was only 10% of wt p33 (Fig. 2.6B). The 
accumulation of A210A211 p33 was comparable to wt p33. The reduced 
accumulation of phosphorylation-mimicking p33 mutants in plant protoplasts can be 
explained by several alternative models including decreased stability and/or 
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production of these p33 forms. To exclude some of these explanations we further 
analyzed the mutants in a yeast system. 
 
Hypophosphorylation-mimicking p33 mutants affected plus-strand RNA and 
subgenomic RNA synthesis in vivo 
 
To test for possible regulatory roles of phosphorylation of p33/p92 in 
replication, we performed time-course experiments in protoplasts with a viable 
nonphosphorylation-mimicking mutant, a hypophosphorylation mutant (i.e., 
D210A211 carrying only a single D mutation), and the wt (Fig. 2.6). Total RNA 
samples were prepared from protoplasts and analyzed with Northern blotting as 
described above. These experiments revealed that nonphosphorylation-mimicking 
A210A211 and the partial (hypo)-phosphorylation-mimicking D210A211 mutants 
generated 5–6 times more subgenomic (sg) RNA2 than sgRNA1 at early time points, 
whereas sgRNA2 was approximately 3-fold more abundant than sgRNA1 in the wt 
CNV infections (Fig. 2.6A). Altogether, sgRNA2 was the most abundant viral RNA 
species in A210A211 and D210A211 infections, in contrast to wt CNV, which 
produced the gRNA in the largest amount (except at the early time point, Fig. 2.6A). 
These data suggest that phosphorylation status of S210 and T211 in p33/p92 could 
affect the level and ratio of sgRNA1 and sgRNA2 synthesis in CNV infections. 
To test if mimicking mutations could also affect minus- versus plus-strand 
synthesis during CNV replication, we took advantage of DI-72 RNA replicon, which 
produces minus-strand RNA at easily detectable levels (Monkewich et al., 2005). In 
this assay, N. benthamiana protoplasts were co-electroporated with wt or mutated 
(A210A211, A205A210A211, and D210A211) CNV RNA and DI-72 RNA, followed 
by detection of plus- and minus-strand DI-72 RNA levels in total RNA samples by 
Northern blotting (Fig. 2.7). We observed that DI-72 minus-strand synthesis took 
place at low levels (10–20%) between 4 and 12 h postinfection (hpi), followed by 
increased synthesis between 12 and 24 h in the presence of wt or any of the mutated 
helper CNV. On the contrary, plus-strand RNA synthesis showed remarkable 
differences depending on the wt and mutated helper CNV (Fig. 2.7A). For example, 
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detectable level of DI-72 plus-strands was observed as early as 6 and 8 hpi in the 
presence of wt CNV helper, whereas A205A210A211 and D210A211 mutants of 
CNV accumulated DI-72 plus-strands at a detectable level only at 12 hpi (Fig. 2.7A). 
Interestingly, the relative level of minus-strand accumulation (when compared to wt 
level of minus strands representing 100%) supported by A205A210A211 and 
D210A211 mutants was 20% higher than the relative level of plus-strand 
accumulation (Fig. 2.7C). The altered ratio between minus and plus-strand 
accumulation means that the RNA synthesis was less asymmetrical with the above 
mutants than in the case of wt CNV replicase. Overall, these observations indicate 
that the phosphorylation status of p33 at positions 205, 210, and 211 might affect the 
level of asymmetry between plus-versus minus-strand synthesis. 
 
Phosphorylation-mimicking mutations inhibit the function of p33 more than p92 
in protoplasts 
 
To test if phosphorylation-mimicking mutations inhibit p33 and/or p92 
functions in plant cells, we utilized a two-component complementation-based 
replication assay developed by Oster et al. (Oster et al., 1998), which allows separate 
mutagenesis of p33 and p92. Expression of p33 and p92 (the p92 ORF contains a 
tyrosine mutation to suppress termination at the end of p33 ORF, Fig. 2.8A) from two 
separate RNAs leads to efficient replication of DI-p33, whereas CNV-Y replicates 
poorly in N. benthamiana protoplasts (Figs. 2.8B–C and (Panaviene et al., 2003; 
Panaviene and Nagy, 2003). We found that co-expression of the unmodified p92Y 
with D210D211 mutation in p33 led to undetectable level of DI-p33 replication (Fig. 
2.8B), suggesting that phosphorylation renders p33 nonfunctional. On the contrary, 
the D210D211 mutation in p92Y inhibited wt DI-p33 replication by only 50% (Fig. 
2.8C), suggesting that phosphorylation of p92 RdRp protein at 210–211 positions 
interfered with its replication function to a lesser extent than phosphorylation of p33. 
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Yeast-based tombusvirus replication assay confirms a role for the 
phosphorylation status of p33 replication protein in tombusvirus replication 
 
To test if the phosphorylation status of p33 affects its stability and/or 
functions, I took advantage of the availability of TBSV replicon-based replication 
assay in yeast expressing the CNV p33 and p92 replication proteins, which supports 
efficient replication of DI-72 RNA (Panavas and Nagy, 2003). In the yeast system, 
the expression of p33 and p92 is driven from separate expression vectors via the 
constitutive ADH1 promoter. The advantage of the yeast replication system is that we 
can study the replication of the DI-72 RNA without the need of replication and gene 
expression of the helper virus. This allowed us to re-test if several mimicking mutants 
of p33 could support tombusvirus replication in yeast. 
 I found that co-expression of wt p92 together with p33 carrying D for T211 
mutation (see constructs D211, D210D211, A210D211, D205D210D211, Figs. 2.9A–
C) did not result in DI-72 RNA replication, based on undetectable levels of DI-72 
plus- and minus-strands in yeast. Similar mutations at T205 and S210 (see constructs 
D205 and D210, Figs. 2.9A–C) also reduced replication of DI-72 RNA (down to 12 
and 8% of wt levels), but to a lesser extent than observed in plant cells. Western blot 
analysis of total protein extracts of yeast strains revealed that, unlike in the plant 
protoplast-based replication assay, the p33 levels in yeast were similar for wt and the 
mutated p33 (Fig. 2.9D), suggesting that the stability of p33 is not altered by these 
mutations. Instead, these data indicate that the phosphorylation-mimicking D 
mutations make p33 less functional/nonfunctional in tombusvirus replication. On the 
contrary, the nonphosphorylatable A mutations had less pronounced effects on p33 
functions (16–57% level of replication, see constructs A210A211, A205A210A211, 
Figs. 2.9A–C). 
I also tested the ability of p33 mutants to support plus- versus minus-strand 
synthesis of the replicon RNA in yeast. Northern blot analysis of total RNA samples 
revealed that the relative levels of minus-strand (as compared to wt level representing 
100%) versus plus-strand accumulation were 2-to-5-fold higher in case of four out of 
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five functional p33 mutants (i.e., A210A211; A205A210A211; D210A211; and 
D205, Figs. 2.9B–C) than that observed with wt p33. However, one p33 mutant (i.e., 
D210) showed lower relative level of minus-strand versus plus-strand synthesis (Figs. 
2.9B–C). Altogether, these data indicate that nonphosphorylation or partial 
phosphorylation-mimicking mutations in p33 at positions 205, 210, and 211 
selectively decrease the level of plus-strand RNA accumulation, likely resulting from 
less asymmetrical RNA synthesis. 
 
Delayed accumulation of a nonphosphorylation-mimicking mutant in N. 
benthamiana plants 
 
To test if CNV expressing the nonphosphorylation-mimicking A210A211 p33 
mutant could replicate with similar efficiency as the wt CNV (expressing 
phosphorylation-competent p33) in whole plants, I extracted total RNA from CNV-
infected leaves 5, 7, and 14 days after inoculation (dpi). I found that wt CNV 
accumulated viral-specific RNAs to higher levels than A210A211 did at 5 and 7 dpi 
(Fig. 2.10A), suggesting that virus replication/accumulation is more robust in wt 
CNV infections. Interestingly, the difference in accumulation level between wt and 
A210A211 gRNA was more significant in plants than in protoplasts (2-to-2.5-fold 
difference in plants at 5 and 7 dpi versus 5% in protoplast at 24 hpi). This might be 
due to an indirect effect of phosphorylation of wt p33 on cell-to-cell movement 
and/or stability of gRNA. The symptoms caused by the wt CNV infection were also 
more intensive than in A210A211 infections (Fig. 2.10B), and led to the death of 
most leaves by 14 dpi. On the contrary, symptoms caused by A210A211 were mild 
and did not lead to necrosis. Interestingly, viral RNA accumulation was 3-fold higher 
in A210A211-infected than in wt CNV-infected plants at 14 dpi, likely due to the 
sickness of wt CNV-infected plants (Fig. 2.10A). Altogether, these data demonstrate 
that the nonphosphorylatable A mutations at positions 210 and 211 in p33 have 
pronounced effects on the pathogenecity of CNV in N. benthamiana. 
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Discussion 
 
Detection of phosphorylated replication proteins in plus-strand RNA virus-
infected hosts is a challenging task due to the low abundance of viral replication 
proteins, their localization to less amenable cellular membranes, the dynamic and 
reversible nature of phosphorylation, and temporally existence of some 
phosphorylated proteins. By using both anti-phosphothreonine antibody-based 
Western blot and phosphoprotein-specific staining assays, I demonstrated the 
accumulation of phosphorylated CNV p33 (and the related TCV p28) replication 
protein in plants, while I could not detect phosphorylated CNV p92, possibly due to 
its very low abundance (approximately 20-fold less than p33; (Scholthof et al., 1995). 
In addition, I obtained a partially-purified kinase preparation from solubilized 
membrane-enriched fraction of N. benthamiana, which was able to phosphorylate the 
CNV p33 replication protein at conserved S/T residues (likely at T205, S210, and 
T211) adjacent to the RPR motif, an RNA-binding site (Panaviene et al., 2003; 
Rajendran and Nagy, 2003). On the contrary, the solubile (cytoplasmic) fraction of 
cells did not contain kinases capable of phosphorylation of the same region in p33 in 
vitro (not shown). Because p33 is membrane-associated in cells and tombusvirus 
replication occurs in membrane-containing compartments (Scholthof et al., 1995; 
Rubino and Russo, 1998; Navarro et al., 2004; Panaviene et al., 2004; Panavas et al., 
2005) it is likely that phosphorylation of p33 takes place in cellular membranes 
(peroxisomal membrane for CNV; (Panavas et al., 2005) in infected cells. Thus, the 
kinase(s) present in the membrane-enriched fraction is likely responsible for in vivo 
phosphorylation of p33. This host kinase is functionally similar to PKC, based on 
phosphorylation site prediction and demonstration that purified PKC preparation 
could also phosphorylate recombinant p33 at residues S210 and T211 in vitro (Fig. 
2.4). Altogether, I conclude that p33 gets phosphorylated in CNV-infected 
plants by a membrane-associated host kinase. 
The effects of p33 phosphorylation during CNV infection were studied using 
phosphorylation-mimicking mutants (see rationale in the results section). The 
advantage of using mimicking mutants is that it simplifies the interpretation of data 
due to the presence of p33 representing either the “nonphosphorylated” (i.e., alanine 
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mutants) or “phosphorylated” (aspartic acid mutants) forms of p33 during the entire 
infection. Disadvantage is that the dynamics of phosphorylation cannot be fully 
examined with these mutants. Nevertheless, based on data obtained with the 
mimicking mutants, the model predicting that the nonphosphorylated form of p33 (I 
refer only to phosphorylation of T205, S210, and T211 in the text below) is the 
functional form is supported, while the fully phosphorylated form of p33 seems to be 
nonfunctional in replication. Accordingly, in vitro phosphorylation of p33 and 
phosphorylation-mimicking mutations in p33 (at S210 and T211 positions) both 
inhibited the ability of p33 to bind to the viral RNA in vitro (see (Stork et al., 2005), 
suggesting that phosphorylation and mimicking mutations had similar effect on p33 
function. However, I cannot completely exclude that results obtained with D mutants 
could possibly cause changes in the structure of p33 unrelated to phosphorylation. 
 The mimicking mutants were also useful to demonstrate that similar 
phosphorylation of p92 RdRp protein (at T205, S210, and T211), which overlaps with 
p33 within its N-terminus, had only limited effect on its activity in protoplasts. Thus, 
I suggest that phosphorylation at T205, S210, and T211 mainly affects p33 
function(s) during CNV infections.  
In addition to the nonphosphorylated and fully phosphorylated forms of p33, I 
suggest that hypophosphorylation of p33 at either T205, S210, or T211 positions 
might affect its activity/function. For example, I observed changes in the ratio of 
sgRNA1 versus sgRNA2 and of plus- versus minus-strand levels (i.e., strand 
asymmetry was reduced) with mimicking mutants affecting only one or two of the 
predicted phosphorylation sites. These observations open up the possibility that 
hypophosphorylation of p33 might be involved in (i) timing and/or fine tuning of 
subgenomic RNA synthesis (sgRNA1 versus sgRNA2) and (ii) controlling the timing 
and/or ratio of plus- versus minus-strand synthesis. For example, 
hypophosphorylation of p33 might modify the activity of the CNV replicase, 
affecting the timing of production of different viral RNA species and the ratio of 
replication products. In contrast, full phosphorylation of p33 (especially 
phosphorylation of T211 seems to be the most critical) might shut down replication, 
which could be beneficial for viral RNA encapsidation, cell-to-cell movement, and 
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other processes by releasing the viral RNA from replication (see the accompanying 
paper by Stork et al., 2005). Indeed, the nonphosphorylated A210A211 mutant 
showed delay in gRNA accumulation in systemically infected leaves when compared 
to the wt CNV, suggesting less efficient virus spread in plants and/or decreased 
stability of mutant A210A211 gRNA. 
The amount of p33 replication protein was not the same in infections with wt and 
phosphorylation-mimicking CNV mutants in N. benthamiana protoplasts (Fig. 2.5 
and Fig. 2.6). For example, protoplasts containing a replication incompetent mutant 
(D210D211) and an inefficiently replicating mutant (D210A211) accumulated p33 at 
undetectable and reduced levels, respectively (Fig. 2.5 and Fig. 2.6). This suggests 
that phosphorylation-mimicking aspartic acid mutations (and analogously 
phosphorylation) might promote rapid p33 degradation, thus affecting the stability of 
p33. Although I cannot fully exclude that the above D mutations facilitate p33 
degradation, this model is not supported by the observation that the amounts and 
stability of wt and phosphorylation-mimicking D mutants of p33 were comparable in 
yeast, expressing these proteins constitutively from plasmids (Fig. 2.9D).  
Alternatively, it is possible that reduced accumulation of p33 carrying the 
phosphorylation-mimicking mutations is due to the production of a limited amount of 
new CNV RNA progeny in cells. I propose that some of the new CNV RNA progeny 
could participate in new rounds of translation to boost p33/p92 production, and thus 
replication, in infected cells. The proposed translational boost might not take place for 
CNV RNA expressing p33 with the phosphorylation-mimicking mutations that 
produce only limited amount of new progeny plus-strands. 
The phosphorylation sites studied in this paper are located adjacent to the 
positively charged RNA-binding domain in p33 (Fig. 2.1B). Therefore, it is possible 
that the observed effects of the phosphorylation-mimicking mutants on CNV 
replication are due to altered RNA-binding capacity of p33. Accordingly, I show in 
the next chapter the inhibitory effect of phosphorylation of these sites on RNA-
binding by the recombinant p33. Thus, phosphorylation of p33 is likely an important 
step in CNV replication by affecting replicase and template interactions. 
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Materials and methods 
 
Detection of phosphorylated p33 and p28 replication proteins by Western 
blotting using phosphothreonine specific antibody or by staining with 
phosphoprotein-specific dye 
 Leaves (2 g) of N. benthamiana plants systemically infected with CNV and 
TCV, respectively, were used to obtain the membrane-enriched and soluble fractions 
as described (Panaviene et al., 2004), except that I included phosphatase inhibitor mix 
containing 25 mM NaF, 10 mM benzamidine, 10 mM sodium orthovanadate. 1/10th 
of the obtained membrane-enriched fraction was loaded on a 10% SDS-PAGE gels, 
electrophoresed, transferred to PVDF membranes, followed by using anti-
phosphothreonine and anti-phosphoserine antibodies as recommended by the 
manufacturer (Research Diagnostic, Inc). 
The second method to detect phosphorylated p33 in CNV-infected N. 
benthamiana was based on using the phosphoprotein specific Pro-Q Diamond dye 
from Molecular Probes. First, I prepared the membrane-enriched fraction (see above), 
followed by solubilization of membrane-bound proteins with 2% Triton X-100 as 
described (Nagy and Pogany, 2000; Panaviene et al., 2004). Anti-p33 antibody 
(prepared against CVGYLKNTPENRLIY peptide, Sigma-Genosys) was then added 
to the sample, followed by incubation in the cold room and then addition of protein A 
(Sigma) and further incubation for 60 min. The pellet was recovered after 
centrifugation, washed three times, and then loaded on an SDS-PAGE gel. The gel 
was then fixed overnight with 200 ml 10% acetic acid (glacial) and 50% methanol, 
followed by three time wash with 200 ml deionized water for 15 min. Staining of the 
gel was done overnight in the dark with 50 ml Pro-Q Diamond dye as recommended 
by the manufacturer (Molecular Probes). Destaining was done with 200 ml 10% 
methanol and 7% acetic acid for 30 min. Images of gels were taken when illuminated 
with 302 nm UV light. 
Preparation of host kinase-containing fraction from N. benthamiana and in vitro 
phosphorylation of p33 
Young leaves (5 g) of uninfected N. benthamiana were used to obtain the 
membrane-enriched fraction (see above), followed by solubilization with 4% Triton 
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X-100 exactly as described for preparation of CNV replicase (Panaviene et al., 2004). 
The solubilized membrane-enriched preparation was passed through Sephadex G-25 
resin (Amersham). To reduce the background in subsequent assays, the obtained host 
kinase preparation was mixed with phosphorylation buffer (0.1 M HEPES pH 7.4, 10 
mM EDTA, 5 mM DTT, 50 mM MgCl2) in the presence of 1 mM ATP to allow 
phosphorylation of any phosphorylatable proteins that might be present in the 
preparation for 20 min at room temperature (RT). This was followed by removal of 
ATP on a Sephadex G-25 column. 
To test phosphorylation of CNV p33 in vitro by the above kinase-containing 
plant membrane preparation, I selected two purified recombinant p33-derived 
peptides, termed C10 (p33181–240) and C11 (p33211–240) (Rajendran and Nagy, 
2003), expressed in E. coli. The cleavage of the proteins was done with Factor Xa 
protease (NEB) as described (Rajendran and Nagy, 2003). The in vitro 
phosphorylation reaction was made in 20 μl volume in the phosphorylation buffer 
(see above), plus 1 μl γ32P-ATP (7000 Ci/mmol, 0.05 mCi), 2 μl kinase-
containing plant membrane fraction, and 3 μg of p33-derived peptide. After 
incubation for 20 min, the samples were run in SDS-PAGE gels, stained with 
coomassie blue, dried and exposed to a phospho-storage screen, and imaged with a 
PhosphorImager. 
 
In vitro phosphorylation of p33 with PKC 
 
The affinity-purified p33 mutants (200 μg/ml, expressed in E. coli) 
(Rajendran et al., 2002), carrying or lacking the T205, S210, and T211 positions, 
were phosphorylated in 20 μl volume containing PKC-phosphorylation buffer (20 
mM HEPES, 0.03% triton X-100, 4 mM MOPS, 5 mM β-glycerol phosphate, 1 mM 
EGTA, 0.2 mM Na-orthovanadate, 0.2 mM DTT), 0.1 mM ATP (unlabeled), 5 μl 
PKC lipid activator (Upstate), 1 μl 2 mM CaCl, 2.5 μl γ32P-ATP (7000 Ci/mmol, 
0.125 mCi), and 0.5 μl PKC (Sigma), for 15 min at room temperature. Afterwards, 
the samples were boiled in SDS-PAGE running buffer for 3 min and loaded onto a 
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large 10% SDS-PAGE gel (Bio-Rad protean II xi). The electrophoresis was 
performed at 200 V for 6 h, followed by staining with coomassie blue, drying, and 
then scanning by a PhosphorImager. 
 
Construction and testing of the phosphorylation-mimicking mutants of CNV p33 
in N. benthamiana protoplasts and plants 
 
To make site-directed mutations that replaced S/T residues with A/D residues, 
I used standard Quick Change XL Site-Directed Mutagenesis Kit (Stratagene) as 
described before (Panaviene et al., 2003) based on an infectious CNV clone (Rochon, 
1991). The mutant clones were confirmed by sequencing, using Beckman Coulter 
DTCS Quickstart Kit and primer #958 (5′-
CCGGCACGGGAGCTCAAGGGTAAGGA). 
Full-length RNA transcripts of CNV (Rochon, 1991), DI-72, and DI-73 
(White and Morris, 1994, 1994) were prepared using standard in vitro transcription 
reaction with T7 RNA polymerase on SmaI linearized DNA templates. N. 
benthamiana protoplasts were prepared as described before (Panaviene et al., 2003). 
Protoplasts were divided into aliquots (5 × 105 protoplasts) and electroporated with 
5 μg of wt or mutated CNV gRNA and 1 μg of DI RNA (when the goal was to test 
DI RNA replication). After electroporation, protoplasts were incubated in the dark at 
22 °C. 
 N. benthamiana plants were rub inoculated with 3 μg of wt or mutated CNV 
gRNA. Inoculated plants were kept in the green house. Samples were taken after 5, 7, 
and 14 dpi. 
 
CNV RNA extraction and Northern blotting 
 
Total RNA was prepared from protoplast or plants using a standard 
phenol/chloroform method (Kong et al., 1997; Nagy et al., 2001) and the samples 
were electrophoresed in 1.2% agarose (in case of gRNA) or 4% polyacrylamide/8 M 
urea gels (for DI-72 RNA). The RNA was then transferred from the gels to Hybond 
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XL membrane (Amersham-Pharmacia) by electrotransfer and hybridized with CNV-
specific probes for the 3′ noncoding region as described (Panaviene et al., 2003). 
Hybridization was done in ULTRAhyb hybridization buffer at 68 °C as recommended 
by the supplier (Ambion). The riboprobes were made in an in vitro transcription 
reaction with T7 RNA polymerase in the presence of [32P]UTP as described. The 
CNV DNA template was obtained using PCR with pair of primers  
#16 (GTAATACGACTCACTATAGGGCTGCATTTCTGCAATGTTC) and  
#312 (GCTGTCAGTCTAGTGGA) for detection of plus-strands, and with #31 
(GTAATACGACTCACTATAGGAAATTCTCCAGGATTTC) and #806 
(CCGTCTAGAGTCGTCGTTTACTGGAAGTTAC) for detection of minus-strands. 
The template for detection of DI-72 RNA (+) and (-) strands (corresponding to 
RIII/RIV) was obtained with PCR using primers #1165 
(AGCGAGTAAGACCAGACTCTTCA) and #22 
(GTAATACGACTCACTATAGGGCTGCATTTCTGCAATGTTCC) versus #157 
(GGGTTTCATAGAAAAGAAAACAAAACC) and  
#18 (GTAATACGACTCACTATAGGAGAAAGCGAGTAAGACAG), respectively. 
The two component, trans-complementation assay was performed in N. 
benthamiana protoplasts with selected mutants as described earlier (Panaviene et al., 
2003). The mutant clones were confirmed by sequencing, as described above. 
 
Western blot analysis 
 
Total proteins from N. benthamiana plant or protoplasts infected with CNV 
were prepared as described (Panaviene et al., 2004). The samples were run in 10% 
SDS-PAGE, followed by transfer onto PVDF membrane (Bio-Rad). 
Immunodetection of p33 protein in the Western blot was performed by using anti-p33 
antibody (generous gift of H. Scholthof). 
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Analysis of replicon RNA accumulation in yeast 
 
S. cerevisiae strain INVSc1 (Invitrogen) transformed with three plasmids [i.e., 
pGAD-His92, pGBK-His33 and pYC-DI-72(+)Rz; (Panaviene et al., 2004)] 
Purification of the cucumber necrosis virus replicase from yeast cells: role of 
coexpressed viral RNA in stimulation of replicase activity, J. Virol. 78 (2004) (15), 
pp. 8254–8263. (Panaviene et al., 2004) was grown in SC-ULT-medium containing 
2% galactose for 24 h at 30 °C (Panavas and Nagy, 2003). To extract total RNA from 
yeast, equal volumes of RNA extraction buffer (50 mM sodium acetate, pH 5.3, 10 
mM EDTA, 1% SDS) and water-saturated phenol were added to the pelleted cells 
(Panavas and Nagy, 2003). Agarose gel electrophoresis and Northern blotting were as 
described above (Pogany et al., 2005). 
Western blot to detect accumulation levels of His-tagged p33 was performed 
as described earlier (Pogany et al., 2005) using monoclonal anti-His antibodies 
(Amersham) and secondary alkaline phosphatase-conjugated anti-mouse antibody 
(Sigma). Western blots were developed using BCIP and NBT (Sigma). 
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Fig. 2.1 Location of the predicted phosphorylation sites in the CNV replication 
proteins. (A) The CNV genomic RNA containing five open reading frames (indicated 
with boxes) and noncoding sequences (solid lines) is shown schematically. (B) The 
known functional domains in p33 are shown schematically at the top. The amino acid 
sequence of the RPR-motif and the predicted phosphorylation sites are shown for 
selected members of Tombusviridae. The following abbreviations were used: TBSV, 
Tomato bushy stunt virus (cherry strain); CNV, Cucumber necrosis virus; AMCV, 
Artichoke mottled crinkle virus; CymRSV, Cymbidium ringspot virus; PLV, Pear 
latent virus; PNSV, Pelargonium necrotic spot virus; CBV, Cucumber Bulgarian 
virus; CIRV, Carnation Italian ringspot virus; and TCV, Turnip crinkle virus 
(Carmovirus, Tombusviridae). 
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Fig. 2.2 Detection of in vivo phosphorylated replication proteins of CNV and TCV. 
(A) Detection of CNV p33 in the enriched membrane fraction by using anti-p33 
antibody. (B) Detection of phosphorylated CNV p33 and TCV p28 proteins in 
membrane-enriched fractions prepared from mock-, CNV-, and TCV-infected N. 
benthamiana plants by Western blotting with anti-phosphothreonine antibody. 
Replication proteins p33 of CNV and p28 of TCV are indicated by arrowheads, 
whereas a band of unknown origin (present only in samples from CNV-infected 
plants) is marked with an asterisk. (C) Detection of CNV p33 in membrane-enriched 
fraction of N. benthamiana by staining with phosphoprotein-specific Pro-Q Diamond 
dye. The CNV p33 was captured on protein A column with anti-p33 antibody from 
the membrane-enriched fraction prior to loading to SDS-PAGE. 
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Fig. 2.3 In vitro phosphorylation of p33 by a plant kinase. (A) Two peptides derived 
from p33 were expressed as an MBP fusion in E. coli, affinity-purified, cleaved off 
from MBP with Factor Xa, and treated with a membrane-enriched preparation 
obtained from healthy N. benthamiana plants in the presence of γ-[32P]ATP. The 
arrowhead shows the phosphorylated peptide (p33211–240), whereas asterisk 
pinpoints the nonphosphorylated peptide (p33219–240). (B) Coomassie blue-stained 
SDS-PAGE shows the migration of the two peptides used in the phosphorylation 
assay 
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Fig. 2.4 In vitro phosphorylation at S210 and T211 residues of p33 by PKC. (A) A 
p33-derived peptide (p33205–234) and its derivatives with the shown mutations were 
expressed as MBP fusions in E. coli, affinity-purified and treated with PKC in the 
presence of γ-[32P]ATP. The arrowheads show the phosphorylated peptides, 
whereas asterisks pinpoint phosphorylated PKC and high molecular weight proteins 
of unknown origin (B) Coomassie blue-stained SDS-PAGE shows the migration of 
the peptides (marked with an arrowhead) used in the phosphorylation assay. (C) 
Detection of PKC-mediated phosphorylation of S210 using anti-phosphoserine 
antibody. The reagents used in this assay were the same as in panel A. After the in 
vitro phosphorylation assay, the samples were loaded on an SDS-PAGE gel, blotted 
to a PVDF membrane, and treated with anti-phosphoserine antibody. Additional 
details are as described in panel A. 
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Fig. 2.5 Comparison of accumulation of CNV gRNA carrying phosphorylation-
mimicking mutations adjacent to the RPR-motif in p33/p92 gene. The full-length, 
infectious CNV gRNA (2 μg) was electroporated into N. benthamiana protoplasts (5 
× 105 cells per experiment). Total RNA was isolated, electrophoresed and blotted 
onto a nylon membrane, followed by probing with 32P-labeled RNA specific for 
gCNV (see Materials and methods). The same amount (5 μg) of total RNA was used 
for loading onto the gels (based on the estimation of the host ribosomal RNA in 
ethidium bromide-stained gels). The positions of the CNV gRNA, sgRNA1, and 
sgRNA2 are depicted on the right. The names of the constructs are shown on the top. 
The samples were taken 12 and 24 h after electroporation. The experiment was 
repeated three times. (B) The ability of CNV mutants to support DI-73 RNA 
replication in trans. The full-length DI-73 RNA (1 μg) was co-electroporated with 
the infectious CNV gRNA (2 μg, mutated or wt) into N. benthamiana protoplasts (5 
× 105 cells per experiment). Sample preparation and Northern blotting was done as 
described in the legend to panel A, except the probing was done with 32P-labeled 
RNA specific for DI-73 RNA (see Materials and methods). (C) Accumulation of 
CNV p33 at 24 hpi. Western blot of total protein extracts was done with anti-p33 
antibody. 
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Fig. 2.6 Effect of phosphorylation-mimicking mutations on accumulation of (A) CNV 
(+)RNAs and (B) p33 replication protein. The relative accumulation levels of CNV 
RNAs are compared to wt CNV gRNA accumulation at 24 hpi (100%). The bottom 
line shows the ratio of sgRNA2 versus sgRNA1 in each sample. The arrowheads 
indicate the position of p33 in the blot. 
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Fig. 2.7 Effect of phosphorylation-mimicking mutations on accumulation of DI-72 
RNA in trans. The relative accumulation levels of (A) plus-stranded and (B) minus-
stranded DI-72 RNAs are compared to infections containing the wt CNV gRNA 
accumulation at 24 hpi [100% separately for both (+) and (-)RNAs, indicated by solid 
and dotted lines, respectively]. (C) Graph showing the relative accumulation of (+) 
and (-) strands in wt and mutated CNV infections in N. benthamiana protoplasts. 
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Fig. 2.8 Phosphorylation-mimicking mutations affect the function of p33, and a lesser 
extent, p92. (A) Schematic representation of the two constructs used in two 
component complementation-based replication studies. The stop codon at the end of 
the p33 gene in gCNV-Y was mutated to a tyrosine codon (Y) to prevent the 
production of p33 from this RNA. The second RNA (DI-p33) was derived from a DI 
RNA that carried a translation competent p33 gene. (B) Northern blot analysis of 
replication of DI-p33 mutants in the two-component system. The gCNV-Y RNA (2 
μg) was co-electroporated with DI-p33 (2 μg) carrying a given mutation into N. 
benthamiana protoplasts. Sample preparation and Northern blotting was done as 
described in the legend of Fig. 5. The position of the DI-p33 is depicted on the left. 
(C) Northern blot analysis of replication of gCNV-Y mutants in the two-component 
system. See panel B for details. 
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Fig. 2.9 Effect of phosphorylation-mimicking mutations on DI RNA replication in 
yeast. (A) Ethidium-bromide stained agarose gel showing the accumulation levels of 
DI-72 RNA in yeast total RNA extracts. Yeast strain Sc1 was co-transformed with 
three plasmids coding for full-length wt or mutated p33, wt p92Y and wt DI-72 RNA 
replicon. The position of the DI-72 RNA in the total RNA isolated from transformed 
yeast cells is shown on the right. (B) Northern blot analysis of accumulation levels of 
(+)DI-72 and (C) (-)DI-72 RNA in yeast. The relative level of DI-72 RNA replication 
in yeast [based on quantification of the Northern blot using a PhosphorImager and 
ImageQuant (v1.2) software from three separate experiments], is shown below the 
blots (100% equals with DI-72 RNA levels in yeast expressing wt p33/p92). (D) 
Western blot analysis of the amount of p33 present in yeast with anti-His antibody. 
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Fig. 2.10 Nonphosphorylation-mimicking mutant of CNV shows delay in gRNA 
accumulation and symptom formation in N. benthamiana plants. (A) Northern blot 
analysis of accumulation levels of CNV (+) RNAs in N. benthamiana plants. Samples 
were taken from two systemically infected leaves/plant and two separate plants were 
used in each experiment (top and bottom panels). The relative levels of gRNA, 
sgRNA1, and sgRNA2 are shown below the blots (100% equals with wt CNV gRNA 
level at 7 dpi). (B) Symptoms of mock- and CNV-infected plants at 7 dpi. 
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CHAPTER III 
 
Inhibition of in vitro RNA binding and replicase activity by phosphorylation of the p33 
replication protein of Cucumber necrosis tombusvirus 
 
Introduction 
 
Recent identification of phosphorylation-based modification of p33 (see 
accompanying paper by (Shapka et al., 2005) opens up the possibility that the activity 
of the p33 replication protein might be regulated by 
phosphorylation/dephosphorylation in CNV-infected plants. In vitro phosphorylation 
studies mapped the sites of phosphorylation in p33 to serine (S210) and threonine 
(T211, possibly T205) residues located adjacent to the RNA binding site (Fig. 3.1C). 
Neutral alanine (A) mutations, which mimic the nonphosphorylated form of p33, at 
these sites were found to affect the synthesis of plus versus minus strands and alter 
the ratio between the two subgenomic RNAs. On the contrary, the phosphorylation-
mimicking aspartic acid (D) mutations that, like phosphorylation, introduced negative 
charges at these positions rendered the virus non-infectious in plant protoplasts.  
To determine what functions of p33 might be affected by phosphorylation, in 
the present study, I conducted in vitro RNA binding experiments with recombinant 
p33 preparations. The obtained data demonstrate that D mutations in p33 at the 
phosphorylation sites reduced the ability of p33 to bind to viral RNA, while A 
mutations had lesser effects. I also found that the above D mutations in p33, but not in 
p92, inhibited the activity and/or the assembly of functional replicase complexes in 
yeast. Altogether, I propose that phosphorylation of p33 replication protein is 
involved in regulation of CNV replication due to affecting the ability of p33 to bind 
to the viral RNA. 
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Results 
 
Rationale 
 
Phosphorylation of threonine (T205 and T211) and serine (S210) residues 
adjacent to the arginine (R) and proline (P)-rich RPR motif 
(R213P214R215R216R217P218) (Fig. 3.1) is predicted to affect the ability of p33 to 
bind to the viral RNA. This is because phosphorylation makes these residues 
negatively charged that could “neutralize” the proximal positively charged R residues 
within the RPR motif. Therefore, the negatively charged phosphorylated residues 
could compete with the negatively charged RNA for binding to the positively charged 
RPR motif in p33. Overall, I predict that phosphorylation of p33 might affect two 
functions of p33: facilitating (i) binding/release of the viral RNA to/from the replicase 
complex during replication; and (ii) assembly/disassembly of the replicase complex, 
which in addition to p92, also contains the viral RNA, p33 and possible host factors. 
These models were tested below. 
 
Phosphorylation of p33 adjacent to the RPR motif inhibits viral RNA binding in 
vitro 
 
To test the effect of phosphorylation on the ability of p33 to bind to the viral 
RNA, first, I utilized phosphorylation-mimicking mutants of recombinant p33. The 
phosphorylation-mimicking mutants carried D for T/S mutations, which introduced 
negative charges comparable to that of phosphorylation (Waigmann et al., 2000; 
Jabbur et al., 2001; Freye-Minks et al., 2003; Jia et al., 2004). On the contrary, 
nonphosphorylated form of p33 was mimicked by A for T/S mutations, which 
maintain neutral charges at the phosphorylation sites. Moreover, hypo 
(partial)phosphorylation-mimicking mutants contained a single D mutation at either 
T205, S210 or T211 positions. Importantly, both D and A residues are similar in size 
to T/S residues, thus minimizing the sterical/structural effects caused by these 
mutations. However, it is important to note that D mutations only “mimic” 
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phosphorylation, thus results obtained with D mutants could possibly cause problems 
unrelated to phosphorylation. 
Altogether, I generated nine p33 mutants with A and/or D mutations at the 
phosphorylation sites (Figs. 3.2A–D). These proteins were expressed in E. coli as 
fusion proteins with the maltose-binding protein (MBP) followed by affinity 
purification (Fig. 3.2E) as described (Rajendran et al., 2002; Rajendran and Nagy, 
2003). Note that, instead of the full-length protein, I used a truncated version of p33, 
which lacked the mostly hydrophobic N-terminal domain. The N-terminal domain 
contains membrane-anchoring sequences, and it does not contribute to RNA binding 
in vitro (Rajendran and Nagy, 2003; Pogany et al., 2005). The purified recombinant 
p33 was used in a gel electrophoretic mobility-shift assay (EMSA) (Fig. 3.2) to test 
its binding to a 32P-labeled RNA probe consisting of RII (+)-SL, which includes the 
high-affinity binding sequence p33RE (Pogany et al., 2005). The EMSA experiments 
demonstrated that alanine mutations (see A210A211, Fig. 3.2A), which mimic the 
nonphosphorylated form of p33, had no inhibitory effect on RNA binding by p33. In 
contrast, the phosphorylation-mimicking D210D211 p33 bound to the RNA probe 
poorly when compared to the nonphosphorylated p33 control (Fig. 3.2B). Thus, the 
phosphorylation-mimicking, but not the nonphosphorylation-mimicking mutations, 
inhibited the ability of p33 to bind to the p33RE-containing viral RNA in vitro. 
To test which of the three phosphorylation sites (i.e., T205, S210 or T211) 
have more pronounced effect on RNA binding, I compared additional p33 mutants 
carrying different combinations of A/D mutations at these phosphorylation sites. The 
RNA binding abilities of these recombinant p33 proteins revealed that D mutation at 
position T211 was especially inhibitory on RNA binding (see mutants D211 and 
A210D211, Figs. 3.2B–C). The presence of D residue at position S210 also had 
inhibitory effect on RNA binding (see mutants D210 and D210A211, Figs. 3.2B–C) 
phosphorylation-mimicking D mutation at position 205 had lesser effect on RNA 
binding (compare mutant D205A210A211 with A205A210A211, Figs. 3.2D–E). I 
also tested the RNA binding activity of a triple phosphorylation-mimicking mutant 
(i.e., D205D210D211), which showed minimal RNA binding activity when compared 
to the nonphosphorylation-mimicking mutant (A205A210A211). Altogether, these 
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data suggest that each of the phosphorylation sites (T205, S210 or T211) could be 
involved in regulation of RNA binding by p33, and their relative effects are inversed 
with their distances from the RPR motif (see Discussion). 
To test if the phosphorylation-mimicking mutation could affect the ability of 
p33 to bind to plus- and minus-stranded RNA templates, I used EMSA experiments 
similar to those described above except using full-length model templates 
representing replication-competent defective interfering RNA (termed DI-72 RNA). 
While the wt p33C bound efficiently to both DI-72(+) and DI-72(-) RNA, the binding 
of D210D211 to both RNAs was less efficient (Fig. 3.3). Altogether, these data 
suggest that the overall RNA binding capacity of p33 is inhibited by the presence of 
phosphorylation-mimicking mutations. 
 The second approach to test the effect of phosphorylation on the ability of p33 
to bind to the viral RNA included in vitro phosphorylation of recombinant wt p33 
with protein kinase C (PKC). I used PKC in this experiment because PKC has been 
found to phosphorylate p33 more efficiently than a plant kinase preparation in vitro 
(Shapka et al., 2005). EMSA performed with the kinased p33 demonstrated that the 
phosphorylated recombinant p33 bound to the viral RNA probe up to 3-fold less 
efficiently than the untreated p33 could (Fig. 3.4A). It is likely that PKC treatment 
had inhibitory effect on RNA binding capacity of p33 due to phosphorylation of S210 
and T211 because the nonphosphorylatable A210A211 mutant of p33 did not show 
reduced efficiency of binding in the treated versus untreated samples (Fig. 3.4A). 
Accordingly, PKC has been shown to phosphorylate only S210 and T211, in p33 in 
vitro (see the accompanying paper by (Shapka et al., 2005). 
Because treatment of p33 with PKC inhibited RNA binding only at low p33 
concentrations (Fig. 3.4A, lanes 4–5), it is possible that the residual RNA binding by 
p33 in Fig. 3.4A (lanes 1–3) is due to incomplete phosphorylation of all p33 
molecules present in solution. To test more rigorously if phosphorylated p33 
maintains the ability to bind to the viral RNA probe, I developed a new EMSA assay 
in which p33 was 32P-labeled (Fig. 3.4B), whereas the viral RNA [RII(+)-SL probe, 
Fig. 3.4B, lanes 4–5] was unlabeled. Visualization of the viral RNA with ethidium 
bromide staining and the p33 with Coomassie staining revealed the presence of 
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p33:RNA complexes (Fig. 3.4B, left and middle panels, lanes 4–5) that were not 
present when the mutated ΔC99 RNA, which cannot bind to p33 (Pogany et al., 
2005), was used as a probe (Fig. 3.4B, lanes 2–3). Importantly, the p33:RNA 
complexes were not labeled with 32P (Fig. 3.4B, right panel, lanes 4–5), suggesting 
that the unphosphorylated p33 still present after PKC treatment, but not the 
phosphorylated p33 (32P-labeled), was responsible for the observed shift in 
RNA:protein mobility. Based on these experiments, I conclude that the 
phosphorylated p33 is unlikely to bind to the viral RNA in vitro. 
 
Phosphorylation stimulates RNA release from bound p33:RNA complexes in 
vitro 
 
To test if phosphorylation of p33 could promote the release of the RNA from 
the p33: RNA complex, I treated the prebound p33:RNA complex with PKC (Fig. 
3.4C). This experiment demonstrated that phosphorylation of p33 could promote the 
release, or prevents the re-binding of viral RNA from the complex. The release of 
RNA from the RNA:p33 complex is due to phosphorylation of S210 and T211 
because RNA release after PKC treatment was not observed with the 
nonphosphorylatable A210A211 p33 mutant (Fig. 3.4C). In addition, I demonstrated 
that p33 bound to the viral RNA can be phosphorylated in vitro with PKC (Fig. 
3.4D). Therefore, the obtained data are consistent with a model that phosphorylation 
can stimulate the release of the viral RNA from p33 and/or p33-containing replicase 
complexes. 
 
Phosphorylation-mimicking p33 mutant inhibits the in vitro activity of 
functional CNV replicase complex 
 
To test if phosphorylation of p33 affects the activity and/or the assembly of 
functional replicases in yeast host, I co-expressed one of the p33 phosphorylation-
mimicking mutants with wt p92 and DI-72 RNA as described (Panavas and Nagy, 
2003; Panaviene et al., 2004). To this end, I prepared two types of replicase 
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preparations 40 h after induction of DI-72 RNA transcription from the pYES-DI-72 
expression plasmid. One of the preparations was the membrane-enriched fraction, 
which contained functional preassembled CNV replicase complexes that could 
synthesize new RNA strands using the co-purified (endogenous) DI-72 RNA template 
(Fig. 3.5A) (Panavas and Nagy, 2003; Panaviene et al., 2004). The second preparation 
was obtained by affinity purification of CNV replicase, which is able to use added 
(exogenous) RNA templates for complementary RNA synthesis (Fig. 3.5B) 
(Panaviene et al., 2004). In comparison with the control experiments including wt p33 
and wt p92, which resulted in highly active CNV replicase preparations, the 
membrane-enriched and the affinity-purified D210D211 p33-containing CNV 
replicases were not functional without or with added RNA templates (Figs. 3.5A–B). 
The amounts of p33 present in these CNV replicase preparations were comparable to 
those in the wt p33-containing preparations (Figs. 3.5A–B). Thus, the stability and/or 
expression level of p33 is not affected by the D210D211 mutations in yeast. The 
simplest explanation of these observations is that the phosphorylation-mimicking 
D210D211 p33 inhibited the activity and/or the assembly of functional replicase 
complexes in yeast. 
In vitro testing of the CNV replicase activity in preparations containing the 
nonphosphorylation-mimicking A210A211 and A205A210A211 p33 revealed 
reduced levels of RNA synthesis (between 29 and 45%) in both endogenous and 
exogenous template-containing reactions (Figs. 3.5A–B). This suggests that the 
nonphosphorylated p33 could participate in CNV replicase assembly. However, the 
assembly and/or activity of the CNV replicase containing nonphosphorylation-
mimicking p33 is somewhat less efficient than those containing wt p33 (see 
Discussion). Additional tests revealed that the hypophosphorylation-mimicking D211 
p33 supported the activity of CNV replicase by five-fold less efficiently than the wt 
p33 did (Figs. 3.5A–B). The amounts of p33 present in these CNV replicase 
preparations were comparable (Figs. 3.5A–B). 
To test if a similar phosphorylation-mimicking mutation (i.e., D210D211) 
could affect the activity of p92 RdRp protein, I co-expressed the mutated p92 with wt 
p33 in yeast followed by obtaining CNV replicase preparations. These tests revealed 
46 
 
that phosphorylation-mimicking mutation in p92 did not inhibit the activity of the 
membrane-bound CNV replicase (Fig. 3.5A). This suggests that phosphorylation of 
p92 at positions S210 and T211 is unlikely to affect its polymerase activity in vivo. 
 
 
 
CNV replicase containing nonphosphorylation-mimicking p33 shows reduced 
ratio in plus- versus minus-strand synthesis 
 
Reduction of template activity by CNV replicase preparations containing 
nonphosphorylation-mimicking p33 (Fig. 3.5) suggests that phosphorylation of T205, 
S210 and T211 sites in wt p33 might play a role in optimal CNV replicase assembly 
and/or viral RNA synthesis. To test the effect of phosphorylation of p33 on RNA 
synthesis by the CNV replicase, first, I treated the CNV replicase with PKC prior to 
the replicase assay. As shown in Figs. 3.6A–B, PKC treatment had no significant 
effect on template activity of the CNV replicase bound to its template (endogenous 
RNA, Fig. 3.6A) or on the purified CNV replicase with added template (Fig. 3.6B). 
These data suggest that the preassembled CNV replicase: RNA complex (with the 
RNA likely bound to the p92 RdRp protein in the replicase complex) is not sensitive 
to phosphorylation in vitro. 
In the second assay, I tested the ratio of in vitro synthesized (+) and (-) strands 
by the wt and mutated CNV replicases co-purified with their template RNAs (Fig. 
3.7). Briefly, in this assay, the “membrane-enriched” replicase fraction containing the 
endogenous viral RNA synthesizes complementary RNA in vitro in the presence of 
32P-UTP and the three other ribonucleotides (“replicase run off” experiments). The 
resulting new 32P-labeled RNA strands are then used as probes in RNA blot 
experiments that have the same amounts of denatured plus- and minus-strand RNA 
blotted on the membrane (Panaviene et al., 2004). Measuring the signal strnegth of 
the hybridized (+) and (-) strands of viral RNA, we can estimate the ratio of plus- and 
minus-strand templates present originally in the membrane-enriched fractions. The 
replicase run off experiments revealed that at the early time point (12 h) the CNV 
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replicase containing nonphosphorylation-mimicking p33 mutant (A205A210A211) 
synthesized over 10 times more minus strands than plus strands (Fig. 3.7). On the 
contrary, the wt replicase synthesized almost the same amounts of minus- and plus 
strands. At 18 h time point, the wt replicase produced not, vert, similar6 times more 
plus strands than minus strands, whereas the CNV replicase containing either 
A210A211 or A205A210A211 p33 synthesized only not, vert, similar3× and not, 
vert, similar1.5× more plus strands than minus strands. Interestingly, the difference 
in plus- and minus-strand ratio between the wt and A205A210A211 mutant replicase 
was still not, vert, similar7-fold at 24 h time point, suggesting that replicase with the 
nonphosphorylation-mimicking p33 has lower preference for plus-strand synthesis 
(i.e., less asymmetrical RNA synthesis) than the wt replicase. 
The CNV replicase containing hypophosphorylation-mimicking p33 (i.e., 
D210A211) lacked detectable level of template activity at the early time points, 
whereas it produced not, vert, similar6-fold more plus strands than minus strands at 
the 30 h time point (Fig. 3.7). This suggests that the assembly of CNV replicase is 
inefficient in yeast expressing D210A211 p33, which could be due to inefficient RNA 
binding (Fig. 3.2), thus inefficient template recruitment into replication. 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
Discussion 
 
In this work, I characterized the effects of phosphorylation of conserved S/T 
residues located adjacent to an essential RNA binding domain on the properties of 
tombusvirus p33 replication protein. Specifically, I found that the phosphorylated 
form of p33 showed reduced RNA binding in vitro (Figs. 3.4A–B). Moreover, 
phosphorylation of the p33:viral RNA complex with PKC in vitro promoted the 
release of the viral RNA from the complex (Fig. 3.4C). This was further supported by 
the reduced RNA binding capacity of recombinant phosphorylation-mimicking D for 
S/T mutants of p33 (Fig. 3.2). Altogether, these data are consistent with the model 
(see Fig. 3.1) that the negative charges introduced at T205, S210 and T211 adjacent 
to the RNA binding domain by phosphorylation can inhibit the binding of the 
negatively charged viral RNA to the positively charged RPR motif in p33. Based on 
these characteristics, phosphorylation /dephosphorylation of p33 adjacent to the RNA 
binding site is likely involved in regulation of p33:viral RNA interaction, and it could 
serve as an on/off switch in viral RNA binding/RNA release (see below). 
In vitro testing of CNV replicase complexes obtained from yeast cells 
revealed that the purified CNV replicase containing phosphorylation-mimicking p33 
(i.e., D210D211) lacked replicase activity on an added template (Fig. 3.5B). 
Moreover, the replicase preparation containing D210D211 p33 was also inactive on 
the co-purified RNA template (Fig. 3.5A). The lack of CNV replicase activity could 
be due to deficiency of phosphorylation-mimicking D210D211 p33 in: (i) 
binding/holding to the template during the in vitro reaction (Fig. 3.2); and/or (ii) 
supporting replicase assembly in vivo prior to replicase purification (Fig. 3.6A). This 
is because the viral RNA template is known to stimulate the assembly of functional 
replicase complexes by 40- to 100-fold in tombusviruses (Panaviene et al., 2004; 
Panaviene et al., 2005). On the other hand, it is unlikely that translation and/or 
stability of p33 were altered by these mutations because yeast cells expressed the 
phosphorylation-mimicking D210D211 p33 in comparable amount to wt p33 (Fig. 
3.4). On the contrary, the RdRp function of D210D211 p92 was not altered by these 
modifications, suggesting that phosphorylation of S/T residues adjacent to the RPR 
motif is expected to have different effect on p92 functions than on p33 functions. 
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Based on the above and previous observations (Panaviene et al., 2004; Shapka 
et al., 2005), we propose that the CNV replicase complex in yeast expressing 
phosphorylation-mimicking D210D211 p33 lacks template activity likely because it 
(i) contains reduced amount of viral RNA due to decreased capacity of the mutated 
p33 in RNA binding, which in turn (ii) leads to deficiency in template recruitment 
(Pogany et al., 2005) and (iii) inefficient replicase assembly due to limited amount of 
“RNA assembly platform” for p33, p92 and putative host proteins (Panaviene et al., 
2004). Altogether, inefficient replicase assembly in combination with poor template 
binding and increased RNA release from the replicase complex could explain the lack 
of detectable CNV replicase activity in membrane-enriched and purified replicase 
preparations obtained from yeast expressing D210D211 p33 (Figs. 3.5A–B). 
Altogether, I propose that phosphorylation of T205, S210 and T211 amino acid 
residues in p33 by a host kinase could lead to “shut down” of new replicase assembly 
and recruitment of viral RNA into replication during the late phase of the replication 
cycle. This could help in switching the role of the viral RNA from replication to other 
processes, such as viral RNA encapsidation and possibly cell-to-cell movement in 
infected hosts. In addition, early hyperphosphorylation of p33 in selected host plants 
could lead to resistance against tombusviruses by interference with replicase 
assembly and template binding. 
Interestingly, the activity of preassembled replicase complex was not affected 
by kinase treatment in vitro (Fig. 3.6), suggesting that phosphorylation of p92 RNA-
dependent RNA polymerase within the replicase complex does not alter its ability to 
bind to the RNA template. This could be due to the presence of two extra RNA 
binding regions in p92 in addition to the RPR motif (Rajendran and Nagy, 2003), thus 
allowing the replicase to perform RNA synthesis on templates that are present within 
preassembled replication complexes. 
The wt nonphosphorylated recombinant p33 and the nonphosphorylation-
mimicking A for S/T mutants of p33 bound to viral RNA stably in vitro (Fig. 3.2), 
and they also supported the assembly of functional CNV replicase complexes in yeast 
(Fig. 3.5). These observations are consistent with the model that the 
nonphosphorylated form of p33 is replication-competent, whereas the fully 
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phosphorylated form is replication incompetent. However, both nonphosphorylated 
and phosphorylated forms likely play some, albeit different, roles in tombusvirus 
replication. This is supported by the observation that the CNV replicase containing 
the phosphorylation incompetent p33 (i.e., A210A211 and A205A210A211) showed 
3- to 7-fold reduction in plus- versus minus-strand synthesis when compared to the 
CNV replicase containing the wt p33 (Fig. 3.7). In other words, the CNV replicase 
containing the nonphosphorylation-mimicking p33 produced less plus-stranded RNA 
and/or relatively more minus-stranded RNA than the replicase with the wt p33. This 
could be due to the reduced release rates of viral RNA templates by the 
phosphorylation incompetent p33 from the replication sites or altered functionality of 
the CNV replicase containing A205A210A211 p33. Altogether, I propose that 
phosphorylation plays a role in fine-tuning of the asymmetrical replication process 
(see below). 
The role of phosphorylation of S/T residues adjacent to the RNA binding site 
in p33 in the replication process could be more complex, however, due to the possible 
presence of partially (hypo-) phosphorylated p33 forms (see previous chapter), which 
might have different functions than the fully phosphorylated form of p33 in infected 
cells. Accordingly, hypophosphorylation-mimicking p33 mutants (i.e., D210A211, 
A210D211) showed reduced viral RNA binding in vitro (Fig. 3.2) when compared to 
the nonphosphorylated wt p33. In addition, CNV replicase preparations containing 
D210 p33 showed reduced template activity and produced small amount of plus-
stranded RNA when compared to the replicase preparations with the wt p33 (Figs. 
3.5A–B). Overall, hypophosphorylation of p33 could play a role in regulation of 
subgenomic RNA synthesis and fine-tuning of the asymmetrical replication process. 
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A model on the role of phosphorylation of p33 in regulation of tombusvirus 
replication 
 
The p33 replication protein plays a role in selection of the viral RNA via 
selectively binding to a conserved stem-loop region in the p92 ORF [RII(+)-SL 
representing p33RE] (Monkewich et al., 2005; Panavas and Nagy, 2005; Pogany et 
al., 2005). This selective template binding by p33 is important for recruitment of the 
viral RNA from translation into replication, which takes place in membranous 
structures derived from peroxisomes (Navarro et al., 2004; Panavas and Nagy, 
2005)). Moreover, the p33: RNA complex is essential for the assembly of the viral 
replicase complex (Panaviene et al., 2004), which also contains p92 and possibly host 
factors. Based on data presented in this chapter and the previous chapter  we propose 
that the template selection and replicase assembly functions are performed by the 
nonphosphorylated form of p33, and these processes are inhibited by the 
phosphorylated form of p33. After the assembly of the replicase complex, 
hypophosphorylation of p33 (probably at S210 and T211 positions) could facilitate 
minus-strand and/or subgenomic RNA synthesis. Phosphorylation of p33 at T211 
position (or combined phosphorylation of T205, S210 and T211 sites), however, is 
predicted to decrease the RNA binding capacity of p33 drastically, which could 
facilitate the release of newly synthesized RNA (both genomic and subgenomic) from 
the replication units/sites (Fig. 3.8). Because phosphorylation and dephosphorylation 
of p33 might take place repeatedly in cycles, one replication unit could potentially 
produce and release tombusviral RNA progenies multiple times. Overall, 
phosphorylation of p33 could help in regulating (fine-tuning) the replication and 
infection processes. 
Cellular processes other than p33 phosphorylation (such as protein 
modification, protein degradation, diffusion or membrane rearrangements) could also 
promote the release of viral RNA from the replication units/sites, likely explaining 
why the nonphosphorylatable p33 (either A210A211 or A205A210A211) still could 
support virus replication. However, the nonphosphorylatable p33 mutants are slower 
in replication in single cells, and they are less potent in invading the host plants as 
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rapidly as the wt virus can. Altogether, these deficiencies of the nonphosphorylatable 
p33 in supporting tombusvirus replication could be especially detrimental in 
competitive environment where tombusviruses with phosphorylatable p33 are also 
present. 
One of the proposed roles of p33 phosphorylation adjacent to the RNA 
binding site in fine-tuning the replication process is to regulate/stimulate the release 
of viral RNA from the replication sites. This might be important because the 
nonphosphorylated p33 binds the viral RNA rather tightly, which is advantageous for 
template selection during early steps of replication. On the contrary, at latter steps of 
replication, tight binding between p33 and the viral RNA could slow down the release 
of the newly made viral RNAs from the replication sites. This could be 
disadvantageous because the viral RNA has to participate in other processes, such as 
translation (i.e., sgRNAs), assembly of new replicase complexes, cell-to-cell 
movement and encapsidation. Altogether, the current work promotes a novel, fine-
tuning role for p33 phosphorylation adjacent to the RNA binding site in tombusvirus 
replication. 
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Materials and methods 
 
Expression and purification of recombinant replicase proteins from E. coli 
 
Expression and purification of the recombinant CNV p33 replicase protein 
(termed p33C, lacking the hydrophobic N-terminal domain) were carried out as 
described earlier (Rajendran and Nagy, 2003 and Rajendran et al., 2002). Briefly, the 
expression plasmids carrying wt or mutated p33C sequences were transformed into E. 
coli [Epicurion BL21-CodonPlus (DE3)-RIL (Stratagene)]. Protein expression was 
induced at 14 °C with 0.3 mM IPTG (isopropylthiogalactopyranoside) for 8 h. The 
recombinant proteins were purified using amylose resin column (NEB), as described 
earlier (Rajendran et al., 2002; Rajendran and Nagy, 2003). All protein purification 
steps were carried out in a cold room. The purified recombinant proteins were 
analyzed in a 10% SDS-PAGE for their purity. The Bio-Rad protein assay was used 
to measure the amount of purified recombinant proteins. 
 
Gel mobility shift assay (EMSA) 
 
RNA templates were obtained using T7 RNA polymerase-based transcription 
on PCR templates in the presence of 32P-labeled UTP and unlabeled ATP, CTP and 
GTP as described (Pogany et al., 2003; Pogany et al., 2005). After phenol/chloroform 
extraction and isopropanol/ammonium acetate precipitation, the obtained RNA 
probes were checked by 5% PAGE/8 M urea electrophoresis. 
The affinity purified recombinant proteins (1 μg or as mentioned in the figure 
legends) were incubated with 1 ng of radioactively labeled RNA probe (see above) in 
a binding buffer [50 mM Tris–HCl pH 8.2, 10 mM MgCl2, 10 mM DTT, 10% 
glycerol, 200 ng yeast tRNA (Sigma) and 2 U of RNase inhibitor (Ambion)] at 25 °C 
for 15 min (Rajendran and Nagy, 2003). After the binding reaction, the samples were 
analyzed by 5% non-denaturing polyacrylamide gel electrophoresis in TAE buffer 
performed at 200V in a cold room (Rajendran and Nagy, 2003). The gels were dried 
and analyzed in a PhosphorImager and quantified using ImageQuant v.1.2 
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(Amersham). To study the effect of phosphorylation on the RNA release from p33, 
we treated the prebound RNA:p33 complex (see the binding assay above) with PKC 
(Sigma) as described in the previous chapter prior to electrophoresis. 
 
Yeast transformation and growth 
 
S. cerevisiae strain INVSc1 (Invitrogen) carrying three plasmids [i.e., pGAD-
His92, pGBK-His33 and pYC-DI-72(+)Rz, (Panaviene et al., 2004)] was grown in 
SC-ULT medium containing 2% galactose for 24 h at 30 °C (Panavas and Nagy, 
2003a). Then, the cultures were diluted 10-fold with fresh SC-ULT medium with 2% 
galactose and grown at 23 °C until 0.6–0.7 OD600 (approximately 24 h). Yeast cells 
were then harvested by centrifugation at 2000 × g for 5 min followed by washing the 
pellet with 20 mM Tris–HCl, pH 8.0 and centrifugation. The pelleted cells were re-
suspended in 1 ml of 20 mM Tris–HCl, pH 8.0 buffer, followed by centrifugation at 
21,000 × g for 1 min and storage of the pellet at -80 °C until further use. 
 
CNV replicase assays 
 
First, I obtained “membrane-enriched” CNV replicase preparations, which are 
suitable to test the replicase activity on the endogenous templates present within the 
CNV replicase preparation (Panaviene et al., 2004). Frozen yeast cells were 
homogenized by grinding in liquid nitrogen followed by addition of the extraction 
buffer (200 mM sorbitol, 50 mM Tris–HCl, pH 7.5, 15 mM MgCl2, 10 mM KCl, 10 
mM γ-mercaptoethanol, yeast protease inhibitor mix, Sigma) and centrifugation at 
100 × g for 1.5 min at 4 °C (Panavas and Nagy, 2003a). Because no template was 
added to the in vitro reaction, the replicase preparation could only use the endogenous 
template present within the enriched membrane fraction. The RdRp products were 
phenol/chloroform-extracted, precipitated with isopropanol/ammonium acetate and 
analyzed under denaturing conditions (i.e., 5% PAGE containing 8 M urea (Pogany et 
al., 2003). 
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The second preparation was affinity-purified CNV replicase, which can accept 
exogenous templates. The CNV replicase was purified via metal-affinity purification 
as described (Panaviene et al., 2004). Briefly, the above enriched membrane fraction 
was solubilized in 1% Triton X-100 and 5% SB3-10 (caprylyl sulfobetaine) (Sigma) 
followed by binding to ProBond resin (Invitrogen). After careful washing, the 
recombinant p33 was recovered from the column in the extraction buffer containing 
200 mM imidazole and 0.1% Triton X-100. I used 0.5 μg RNA templates [RI/RIII(-
)] and 25 μl of recombinant CNV replicase (Panaviene et al., 2004). The RdRp 
products were phenol/chloroform-extracted and analyzed under denaturing conditions 
(see above). 
 
Plus- and minus-strand assay 
 
To test the ratio of (+) versus (-) strand synthesis on the endogenous templates 
by the CNV replicase, I obtained the membrane-enriched fraction (see above) 
followed by standard replicase assay in the presence 32P-labeled UTP and the other 
three unlabeled rNTPs followed by phenol/chloroform extraction and isopropanol 
precipitation. The obtained RNA probe and equal amounts of in vitro transcripts of 
DI-72(+) and (-) RNAs, prepared by T7 RNA transcription (see above), were 
denatured separately by heating for 5 min at 85 °C in TE buffer and formamide (in 
1:1 ratio). Then, the DI-72(+) and (-)RNAs were separately blotted onto a Hybond 
XL membrane (Amersham) and crosslinked with UV (GS Gene Linker, Bio-Rad). 
Hybridization was done using ULTRAhyb solution (Ambion) at 68 °C according to 
the supplier's instructions. The 32P-labeled replicase products were used as probes for 
hybridization. 
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Western blot 
 
Aliquots (10 μl) of the enriched membrane fraction from yeast cells or the 
purified p33 preparations in SDS-PAGE sample loading buffer (Sambrook et al., 
1989 J. Sambrook, T. Maniatis and E.F. Fritsch, Molecular Cloning: A Laboratory 
Manual (2nd ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 
(1989).Sambrook et al., 1989) were heated for 5 min at 85 °C, electrophoresed in 
10% SDS-PAGE gels and electrotransferred to a PVDF membrane (Bio-Rad). Then, 
CNV His-p33 was detected with monoclonal anti-His antibodies (Amersham) and 
secondary alkaline phosphatase-conjugated anti-mouse antibody (Sigma) as described 
(Pogany et al., 2005)Western blots were developed using BCIP and NBT (Sigma). 
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Fig. 3.1 Proposed effect of CNV p33 phosphorylation on its ability to bind to the viral 
RNA. (A) The known functional domains in p33 are shown schematically. (B–C) The 
positively charged amino acid sequence of the RPR motif involved in RNA binding 
and the predicted S/T phosphorylation sites are shown. The possible interactions 
between positively and negatively charged moieties are indicated with dotted lines. 
The model predicts that the nonphosphorylated p33 could bind stably to the viral 
RNA, whereas the phosphorylated form might not bind to the viral RNA due to the 
competition between the negatively charged phosphate groups and the RNA. Note 
that the hairpin structure illustrates RII(+)-SL with the C·C mismatch, which 
constitutes p33RE (Pogany et al., 2005). 
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Fig. 3.2 Reduced RNA binding by the phosphorylation-mimicking p33 mutants in 
vitro. (A–D) EMSA was performed with various purified recombinant p33 carrying 
nonphosphorylation-, hypophosphorylation- and phosphorylation-mimicking 
mutations, respectively, at T205, S210 and/or T211 positions. The RNA probe was 
32P-labeled RII(+)-SL, which includes p33RE sequence. The proteins were used in 
increasing amounts (2-fold increase, up to 200 μg/ml). The migration of the unbound 
and bound RNAs is shown on the right of the gel images. The experiments were 
performed three times. (E) Coomassie-stained SDS-PAGE shows that the purified 
p33 preparations had comparable quantity and quality. 
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Fig. 3.3 The nonphosphorylated wt p33 binds both DI-72(+) and (-) RNA more 
efficiently than the phosphorylation-mimicking mutant. EMSA was performed with 
purified recombinant p33 preparations, either wt or D210D211 as described under 
Fig. 2. The p33 protein was used in increasing amounts (2-fold increase, up to 200 
μg/ml), whereas the same amounts of 32P-labeled DI-72(+) and DI-72(-) RNAs were 
applied. The percentage of bound RNA is shown graphically at the bottom. The 
unbound RNA probe in the absence of p33 is taken as 100%. 
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Fig. 3.4 Phosphorylation inhibits the ability of p33 to bind to the viral RNA and 
facilitates the release of bound RNA from the p33: RNA complex. (A) EMSA was 
performed with purified recombinant p33 (wt or A210A211) treated prior to RNA 
binding with PKC in the presence (marked as PKC + ATP) or absence of ATP 
(marked as “PKC-ATP”). The probe was the 32P-labeled RII(+)-SL RNA as 
described in the legend to Fig. 2. The percentage of free RNA is shown graphically at 
the bottom. The free RNA probe in the absence of p33 is taken as 100%. (B) EMSA 
was performed as described in panel A, except that p33 was phosphorylated with 
PKC (lanes 2–5) in the presence of 32P γ-ATP and ΔC99 (lanes 1–3) or wt RII(+)-SL 
(lanes 4–5) RNA probes were unlabeled. Lane 1 contains only the ΔC99 RNA probe 
as a marker. Left panel: the gel was stained with ethidium bromide to visualize the 
RNA probes (ΔC99 and wt RII (+)-SL only differ by 1 nt in length). Note the 
presence of a unique band in lanes 4–5, which represents the p33: RNA complex 
(depicted by a double headed arrow). ΔC99 RNA probe cannot bind to p33 (Pogany 
et al., 2005), thus there is no detectable p33: RNA complex in lanes 2–3. Middle 
panel: the same gel as in the left panel was stained with Coomassie blue to visualize 
p33. Note that the p33: RNA complex (depicted by a double headed arrow) was 
detected only in lanes 4–5 at the same position in the gel when compared with the left 
panel. Right panel: detection of 32P-labeled p33 with a PhosphorImager from the 
same gel shown in the left and middle panels. Note the lack of 32P-labeled p33 (i.e., 
the phosphorylated form of p33) in the area of p33: RNA complex (depicted by an 
asterisk). Therefore, these results suggest that the unphosphorylated form of p33, 
which is apparently still present after PKC treatment, is responsible for the observed 
RNA mobility shift visualized in the left and middle panels. (C) EMSA was 
performed with wt 32P-labeled RII(+)-SL and unlabeled p33 (wt or A210A211) as 
described in panel A, except that the PKC treatment was done after the RNA binding 
reaction (i.e., after the formation of the stable p33:RNA complex). The percentage of 
bound RNA is shown below the gel. The free RNA probe in the absence of p33 is 
taken as 100%. (D) Phosphorylation of purified p33 with PKC using 32P γ-ATP in 
the presence of RII(+)-SL RNA template (0, 1 or 2 μg, as shown). Note that PKC can 
phosphorylate p33 even in the presence of excess amounts of RNA templates. 
 
63 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.5 Phosphorylation-mimicking mutations in p33 inhibit the assembly of 
functional CNV replicase complexes in yeast. (A) In vitro activity of CNV replicase 
present in membrane-enriched preparations. Each replicase preparation, obtained 
from yeast co-expressing p33, p92 and DI-72(+) RNA, was tested with the co-
purified endogenous template (no template was added). 32P-labeled RNA products 
from the above preparations were analyzed on denaturing 5% PAGE/8 M urea gels. 
For quantification, I measured the intensity of 32P-labeled RNA products by using a 
PhosphorImager. Activity of the CNV replicase obtained from yeast expressing the 
wt p33 [in addition to wt p92 and DI-72(+) RNA] corresponds to 100%. Each 
experiment was performed three times. Western blot (at the bottom) shows the p33 
levels in the membrane-enriched preparations. Similar replicase assay with 
membrane-enriched preparations containing mutated p92 and wt p33 is shown on the 
right. Note that phosphorylation-mimicking mutations in 92 (D210D211), unlike in 
p33, did not reduce CNV replicase activity. (B) In vitro activity of affinity purified 
CNV replicase preparations. Each replicase preparation, obtained from yeast co-
expressing p33, p92 and DI-72(+) RNA, was tested in the presence of exogenous 
RI/III(-) template, which contains the minus-stranded regions I and III of DI-72 in a 
standard CNV replicase assay. Analysis of the replicase products and quantification 
were done as described in panel A. Western blot (at the bottom) shows the p33 levels 
in the affinity-purified CNV replicase preparations 
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Fig. 3.6 Phosphorylation does not inhibit the activity of the preassembled functional 
CNV replicase complexes in vitro. (A) Enriched membrane fractions with 
endogenous templates, or (B) affinity-purified CNV replicase preparations 
programmed with RI/III(-) template, were treated with PKC prior to the replicase 
assay. See further details in the legend to Fig. 5. 
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Fig. 3.7 Effect of phosphorylation site mutations in p33 on in vitro asymmetrical 
RNA synthesis by the CNV replicase obtained from yeast. Top: the RNA blots show 
the (+) and (-) strand synthesis by the in vitro CNV replicase. Unlabeled T7 RNA 
polymerase transcripts of DI-72(+) and DI-72(-) (400 ng each), marked as + and =, 
respectively, were blotted on the membrane. The blotted RNAs were then hybridized 
with denatured 32P-labeled RNA probes, which were generated by the CNV replicase 
in vitro on the endogenous templates present in the enriched membrane fractions 
obtained from yeast. Time points for harvesting the yeast samples for isolation of 
enriched membrane fractions are shown on the top. Bottom: the ratio between plus- 
and minus-stranded RNAs in the in vitro replicase assay was calculated based on 
PhosphorImager analysis from three separate experiments. 
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Fig. 3.8 A model on the role of phosphorylation of p33 in CNV replication. (A) At 
the beginning of infection, the freshly translated nonphosphorylated p33 is actively 
involved in the assembly of the CNV replicase, and the recruitment of the viral RNA 
template to membranous vesicles formed on the surfaces of peroxisomes. The single 
vesicle schematically shows a hypothetical replication unit, based on BMV (Schwartz 
et al., 2002), with numerous p33, several p92 and the (+)-stranded viral RNA 
(purple). Hypophosphorylation of p33 might affect the ratio of plus- versus minus-
strand synthesis by the CNV replicase. (B) Phosphorylation of p33 leads to decreased 
RNA binding, thus facilitating the release of the newly synthesized genomic and 
subgenomic RNA progeny from replication. The released viral RNA will likely 
participate in new rounds of translation, cell-to-cell movement and/or encapsidation. 
However, at later time point, the phosphorylated p33 cannot participate in the 
assembly of new CNV replicase complexes, thus resulting in shut down of replication 
(indicated by an “X”). A possible role of phosphorylation in the 
disassembly/degradation of replicase complexes is also shown. 
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CHAPTER IV 
 
 
RNA chaperone activity of the tombusviral p33 replication protein facilitates initiation 
of RNA synthesis by the viral RdRp 
 
Introduction 
  
RNA binding proteins, such as helicases and cofactors, have been proposed to 
play auxiliary roles in RNA virus replication, however  (+)RNA viruses with 
genomes less than 6,000 nt do not code for RNA helicases (Koonin and Dolja, 1993). 
Accordingly, viral-coded RNA chaperones have been shown to participate in the 
replication of picornaviruses, coronaviruses and hepatitis delta virus (Huang and Wu, 
1998; Wang et al., 2003; DeStefano and Titilope, 2006), or affect the packaging of 
coronaviruses, hepatitis C virus, retroviruses and minus-stranded RNA viruses (Rein 
et al., 1998; Cristofari et al., 2004; Levin et al., 2005; Cruceanu et al., 2006; Ivanyi-
Nagy et al., 2006; Mir and Panganiban, 2006, 2006; Zuniga et al., 2007). Host-coded 
RNA chaperones have also been shown to affect calicivirus and viroid RNA 
replication (Daros and Flores, 2002; Karakasiliotis et al., 2006). The unique feature of 
RNA chaperones is that they do not require rNTPs for destabilizing RNA structures, 
but instead, they bind cooperatively to the RNA that leads to structural changes in the 
RNA. Thus, RNA chaperones will profoundly affect the folding process, interactions 
between RNAs and the accessibility of the RNA to other proteins. 
One group of small plus-stranded RNA viruses, which does not code for RNA 
helicases, is tombusviruses. These viruses, including Tomato bushy stunt virus 
(TBSV) and Cucumber necrosis virus (CNV), code for an essential RNA-binding 
protein, termed p33, which is known to affect many steps during the infection 
process. For example, p33 has been shown to bind to a C•C mismatch within an 
internal cis-acting stem-loop element that leads to selective recruitment of the viral 
RNA into replication (Monkewich et al., 2005; Pogany et al., 2005). p33 is also 
involved in the formation of spherule-like structures on the cytoplasmic interface of 
peroxisomal membranes, which represent the site of viral RNA replication 
(McCartney et al., 2005; Panavas et al., 2005; Navarro et al., 2006). Its role in viral 
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pathogenesis has also been documented (Burgyan et al., 2000). In addition to the 
RNA-binding domain, p33 also contains two short p33:p33/p92pol interaction 
domains that are likely important for the assembly of the viral replicase and for RNA 
binding, too (Panaviene et al., 2003; Rajendran and Nagy, 2004; Pogany et al., 2005). 
Phosphorylation close to the RNA-binding domain is thought to regulate the function 
of p33 during replication (Shapka et al., 2005; Stork et al., 2005). Overall, p33 seems 
to be the master regulator of the tombusvirus replication process (Nagy and Pogany, 
2006).    
Based on cooperative RNA binding ability of p33, I speculated that p33 might 
be able to perform many functions during infection via acting as an RNA chaperone 
that modifies the structure of the viral RNA to allow the participation of the viral 
RNA in different ribonucleoprotein complexes. To test this hypothesis, I performed 
biochemical experiments with purified recombinant p33 in in vitro assays. I have 
demonstrated that p33 can stimulate initiation of RNA synthesis by up to 5-fold by a 
viral RNA-dependent RNA polymerase (RdRp) in vitro. In addition, p33 made 
double-stranded (ds)RNA templates sensitive to S1 nuclease, it unwound short 
ssDNA/ssRNA hybrids and stimulated self-cleavage by a ribozyme in vitro. 
Interestingly, p33 required two RNA-binding regions for its RNA chaperone activity. 
Based on these data, I propose a role for the RNA chaperone activity of p33 during 
tombusvirus replication. 
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Results 
  
 We have shown previously that depending on the protein concentration, 
mutations or the composition of the buffer, the tombusvirus p33 auxiliary protein can 
bind to the viral RNA either specifically or non-specifically (Rajendran and Nagy, 
2003; Pogany et al., 2005). The specific interaction between p33 and the viral RNA 
is required for the recruitment of the TBSV (+) RNA to the membrane-bound 
replicase complex (Monkewich et al., 2005; Pogany et al., 2005). However, after the 
selective (+) RNA recruitment, the function of p33 could be different within the viral 
replicase complex, where p33 is present in high amount, reaching ~10-20-fold excess 
over the p92pol (Rajendran and Nagy, 2006; Serva and Nagy, 2006). The high local 
concentration of p33 within the replicase complex could facilitate non-specific 
binding of p33 to the viral RNA in cooperative manner (Rajendran and Nagy, 2003), 
possibly allowing p33 to function as an RNA chaperone within the replicase 
complex. Therefore, I tested if the tombusvirus p33 possesses RNA chaperone 
activity in vitro using purified components. 
 
Strand separation activity of the recombinant p33 on short DNA oligo - RNA hybrid 
in vitro. 
 
To test the possible RNA chaperone activity of p33, I used a strand 
separation assay (Fig. 4.1A). A short ssDNA was 5' end labeled and annealed 
with the unlabeled DI-72 (-)RNA, followed by the addition of purified 
recombinant CNV p33. I have found that 65% of ssDNA/ssRNA hybrid was 
separated by p33 when present in high concentration (Fig. 4.1B, lane 4). This 
result is in agreement with RNA chaperone-like activity of p33, which lacked 
ribonuclease activity (Fig. 4.1C). However, further experiments have shown that 
p33 could not efficiently separate 621 bp long RNA-RNA hybrids under the 
same conditions (not shown), suggesting that the RNA chaperone activity of p33 
is not robust (not shown). 
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P33 replication protein renders a dsRNA template ribonuclease sensitive in 
vitro. 
 
To further test if p33 can open up dsRNA structures, I developed an S1 
nuclease-based assay (Fig. 4.2A). While dsDI-72 was completely resistant to S1 
nuclease digestion under the in vitro conditions (Fig. 4.2B, lanes 1,5, and 9), addition 
of purified recombinant p33 made dsRNA S1 ribonuclease sensitive, leading to RNA 
degradation up to 75% (Fig. 4.2B, lanes 4,8, and 12). The same p33 preparation 
when applied in the absence of S1 did not lead to degradation of dsRNA, excluding 
the possibility that the purified recombinant p33 preparation was contaminated by a 
bacterial ribonuclease (Fig. 4.2C). In addition, p33 lacking the RPR RNA-binding 
domain (construct p33-DRPR)(Rajendran and Nagy, 2003) did not render dsDI-72 
RNA S1 nuclease sensitive (Fig. 4.2D, lanes 2-4). These data are consistent with the 
model that the RNA-binding ability of p33 is critical to render the dsRNA template 
S1 nuclease sensitive. 
 
P33 replication protein facilitates self-cleavage by a ribozyme in vitro. 
 
Since RNA chaperones bind to the RNA nonspecifically and cooperatively, 
like p33 when present in high concentration (Rajendran and Nagy, 2003), they can 
facilitate RNA cleavage by ribozymes (Cristofari and Darlix, 2002; Zuniga et al., 
2007). This property of the RNA chaperones are due to refolding of the ribozyme 
sequence trapped in non-active conformation. To test the effect of p33 on ribozyme 
activity, I used the self-cleaving ribozyme of satellite Tobacco ringspot virus 
(Buzayan et al., 1986; Panavas and Nagy, 2003) in the presence of recombinant p33 
(Fig. 4.3A). I have found that p33 stimulated the ribozyme activity by ~4-fold, 
reducing the amount of uncleaved RNA and increasing the amount of self-cleaved 
RNAs (Fig. 4.3B, lane 3 versus lane 1). This finding supports the model that p33 
could be involved in RNA folding in a sequence non-specific manner. 
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Inhibition of the RdRp-driven RNA synthesis by ssDNA complementary to the 
promoter is neutralized by p33. 
 
Since the RNA chaperone activity of p33 replication protein is likely important 
within the viral replicase complex, I wanted to test if p33 could change the activity of 
a viral RdRp on RNA templates. I have chosen a heterologous RdRp derived from a 
related virus, Turnip crinkle virus (TCV).  The original RdRp protein of TCV, 
termed p88, contains a domain similar to the tombusvirus p33 replication protein that 
might also function as an RNA chaperone. Therefore, I used an N-terminally-
truncated p88, termed p88C, which lacks the domain similar to p33, yet it is a highly 
active RdRp on ssRNA templates in vitro (Rajendran et al., 2002; Panavas et al., 
2006). Unfortunately, the comparable segment of TBSV or CNV p92pol, termed 
p92C, which lacks the p33 overlapping domain, or the full-length p92pol RdRp are 
not active in vitro (not shown), thus preventing the possibility to compare the activity 
of the TCV p88C and the tombusvirus p92C/p92pol. Overall, the advantage of using 
this heterologous system is that the tombusvirus p33 does not interact directly with 
TCV p88C (Rajendran and Nagy, 2004), thus making it unlikely that any stimulatory 
effect of p33 on p88C RdRp activity would be due to direct enhancement of RdRp 
activity (i.e., acting like a transcription factor). Rather, p33 could likely affect RdRp 
activity by altering the RNA template due to its possible RNA chaperone activity. 
To test for the possible RNA chaperone activity of p33 replication protein, I set 
up an in vitro assay based on the p88C RdRp protein and a partial ssRNA/ssDNA 
hybrid (Fig. 4.4A). Since previous studies have established that the accessibility of 
the terminal promoters by the tombusviral or TCV RdRps is a critical factor during 
initiation, I used a short ssDNA complementary to the very 3’ end of DI-72(-) to 
form partial DNA/RNA hybrid within the complementary sequences. I have found 
that the ssDNA inhibited RNA synthesis by ~80% in the RdRp assay (Fig. 4.4B, 
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lanes 2, 6 versus lanes 1, 5). This observation suggests that the initiation site was 
much less accessible to the p88C RdRp in the presence of ssDNA than on the free 
RNA template.  
 
 
Importantly, I have found that the addition of recombinant p33 enhanced p88C 
activity by ~3-fold on the partial ssRNA/ssDNA hybrid (Fig. 4.4B, lane 4 and 8). 
This finding supports the idea that p33 facilitates the accessibility of the cPR 
promoter in DI-72 (-) template by destabilizing the ssRNA/ssDNA hybrid (Fig. 
4.4A). 
 
P33 facilitates initiation of RNA synthesis on dsRNA template by p88C RdRp. 
 
To further test the possible RNA chaperone activity of p33, I used dsDI-72 RNA 
in the p88C RdRp assay. Previous studies have established that p88C was inefficient 
in initiation of RNA synthesis on TBSV dsRNA templates when compared to the ss(-
)RNA template (Panavas et al., 2006). Inefficient initiation on dsRNA templates was 
likely due to poor accessibility of the promoter to the RdRp in the dsRNA when 
compared to ssRNA. However, once initiation takes place, the RdRp can unwind the 
dsRNA structure during strand elongation.  
Using gel-isolated dsDI-72 RNA template in p88C RdRp assay, I found that 
addition of increasing amounts of recombinant p33 enhanced p88C activity by more 
than two-fold (Fig. 4.5A-B, lanes 1-10). This enhancement is not due to stabilization 
of p88C by p33 because the activity of p88C on template dsDI-72(5'D69) with an 
unbase-paired ssRNA tail including the cPR promoter was decreased by the addition 
of p33 (Fig. 4.5B, lanes 11-20). Moreover, deletion of the RNA binding domain 
(construct p33-DRPR) of p33 eliminated the stimulatory effect of p33 on p88C with 
dsDI-72 template (Fig. 4.5C), suggesting that the ability of p33 to bind to the RNA is 
important for stimulation of the RdRp activity on dsRNA template. 
To further test the possible RNA chaperone activity of p33, I used template 
dsDI72 (5'm3-8) (Fig. 4.5D), which has a "bubble structure" that enhances the 
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availability of cPR sequence by p88C RdRp by only 25% (Panavas et al., 2006). 
Interestingly, addition of recombinant p33 to the assay led to ~5-fold increase in 
template activity (Fig. 4.5E, lanes 3-4 and 7-8). Similarly, dsDI-72 (5'D11) (Fig. 
4.5D), which forms a short inhibitory hairpin within the cPR sequence, was used 
~2.5-fold more efficiently by p88C RdRp after addition of the recombinant p33 to the 
assay (Fig. 4.5E, lanes 9-16). The easiest interpretation of these data is that p33, due 
to its RNA chaperone activity, facilitates the initiation step for p88C RdRp by 
opening up the stable secondary structure within the cPR sequence in the dsRNA 
template.     
 
P33 promotes initiation on (+) RNA template by the p88C RdRp. 
 
The (+) RNA template in tombusviruses contains a silencer element that inhibits 
initiation of (-) RNA synthesis due to base-pairing between an internal loop sequence 
of a distant hairpin and the 5 nt 3' terminal sequence, which makes the initiation site 
poorly accessible for the viral RdRp (Fig. 4.4C) (Pogany et al., 2003). To test if the 
chaperone activity of p33 could promote initiation on the (+) RNA template, I used 
DI-72 (+) in our standard p88C RdRp assay in the presence of various amounts of 
recombinant p33. The RdRp assay revealed that p33 enhanced initiation on the (+) 
RNA template by ~2-fold (Fig. 4.4D), suggesting that p33 can facilitate opening up 
the base-pairs formed between the silencer and promoter, thus likely facilitating the 
loading of the viral RdRp on the (+) RNA template.        
 
The C-terminal portion of p33 containing the RNA-binding region is not an 
active RNA chaperone in vitro. 
 
To dissect what domains within the p33 replication protein are needed for RNA 
chaperone activity, first I tested p33C carrying the RPR RNA binding and the S1-S2 
protein-protein interaction domains (Fig. 4.6A) (Panaviene et al., 2003; Rajendran 
and Nagy, 2004, 2006). Addition of p33C to the standard p88C RdRp assay with 
dsDI-72 template revealed a slight inhibitory effect on p88C RdRp activity (Fig. 
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4.6B), instead of the expected stimulatory effect. P33C also strongly inhibited p88C 
RdRp activity on dsDI-72 (5'D69) template (Fig. 4.6C). Based on these observations, 
I suggest that p33C does not have an RNA chaperone activity comparable with the 
full-length p33. 
 
 
 
  
The N-terminal portion of p33 contains an additional RNA-binding region 
required for RNA chaperone activity. 
 
The lack of RNA chaperone activity by p33C indicated that the N-terminal 
region in p33 might also have an RNA binding region that is necessary for RNA 
chaperone activity. Therefore, I tested if the N-terminal segment of p33 could bind to 
the viral RNA in a gel mobility shift experiment. Indeed, construct p33-N1-82 
carrying the N-terminal 82 aa bound to the labeled RNA template in vitro, whereas 
the shorter version (termed p33-N1-72 with 72aa segment) bound less efficiently 
(Fig. 4.6D). These data suggested that the N-terminal portion of p33 contains ssRNA 
binding activity. Further experiments have demonstrated that ssRNA-binding by p33-
N1-82 is non-specific and much weaker than ssRNA binding by p33C (Judit Pogany 
unpublished data).    
To test if the N-terminal segment of p33 contributes to the RNA chaperone 
activity of p33, I made construct p33-D72-130, which lacked the N-proximal RNA 
binding region (between positions 72-82) and a transmembrane segment to increase 
solubility of the recombinant protein in E. coli. When compared with the full-length 
p33, the purified recombinant p33-D72-130 lacked RNA chaperone activity in the S1 
nuclease sensitivity assay (Fig. 4.6E). Thus, the result with p33-D72-130 is similar to 
that obtained with p33C, suggesting that the N-proximal RNA binding region of p33 
is likely part of the functional RNA chaperone. 
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Discussion 
 
A large group of small RNA viruses codes for auxiliary replication proteins that 
lack helicase/ATPase motifs. Among these is the essential p33 replication protein of 
tombusviruses, which has essential functions in RNA replication (White and Nagy, 
2004; Nagy and Pogany, 2006). The ability of p33 to bind to the viral RNA is critical 
during tombusvirus replication and it also affects viral RNA recombination 
(Panaviene et al., 2003; Panaviene and Nagy, 2003; Jaag et al., 2007). Interestingly, 
p33 can bind to the viral RNA in two different fashions. The first type of RNA 
binding by p33 is specific to a region in the plus-stranded TBSV RNA termed 
RII(+)-SL with a signature C•C mismatch (also termed p33 recognition element) 
(Monkewich et al., 2005; Pogany et al., 2005). This specific p33-RNA interaction 
requires small amount of p33, likely in the form of p33 dimer (Pogany et al., 2005). 
The above specific p33-TBSV (+)RNA interaction is critical for the selective 
recognition of the TBSV RNA and its recruitment into replication. The second type 
of RNA binding is non-specific binding of p33 to ssRNA and ssDNA, and to a lesser 
extent to dsRNA (Rajendran and Nagy, 2003). This non-specific nucleic acid binding 
by p33 requires a high concentration of p33 and occurs in a cooperative manner 
(Rajendran and Nagy, 2003). I envision that the non-specific RNA-binding activity 
of p33 is only important within the assembled, membrane-bound tombusvirus 
replicase complex, which contains  a large amount of p33 and only the selectively 
recruited TBSV RNA in addition to p92pol and host factors (Serva and Nagy, 2006). 
Within this context, the RNA chaperone activity of p33 could be important for 
tombusvirus replication (see below).      
Based on in vitro approaches using recombinant p33, I have shown that p33 
could function as an RNA chaperone. The supporting evidence for p33 RNA 
chaperone function includes: (i) up to 5-fold stimulation of initiation of RNA 
synthesis by the heterologous TCV RdRp on dsRNA templates or ssDNA/ssRNA 
hybrids; (ii) enhancing the level of minus-strand RNA synthesis from the minus-
strand initiation promoter (gPR), which is likely due to opening up the silencer- 
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promoter interaction; (iii) Increasing the sensitivity of dsRNA templates to the 
ssRNA-specific S1 nuclease, suggesting that p33 binding to the dsRNA leads to 
unwinding/openining up the structure, and rendering dsRNA nuclease sensitive. (iv) 
Also, strand separation assay with ssDNA/ssRNA hybrids showed unwinding of the 
hybrid in the presence of p33; Moreover, (v) p33 stimulated self-cleavage by a 
ribozyme in vitro, supporting the RNA-folding ability of p33. Further evidence for 
the genuine RNA chaperone activity of p33 is the requirement for the RNA binding 
regions in p33 for RNA chaperone activity, suggesting that p33 must interact with 
the RNA template in order to function as a chaperone. The use of the heterologous 
p88C RdRp with p33 [these proteins do not interact in vitro (Rajendran and Nagy, 
2004)] makes it unlikely that the stimulatory effect of p33 on TCV p88C activity on 
dsRNA templates is due to activation of p88C RdRp. 
Many known RNA chaperones have long intrinsically disordered (unstructured) 
regions, which undergo disorder-to-order transitions upon binding to RNA (Ivanyi-
Nagy et al., 2005). This leads to unwinding (unfolding) of the bound segment of the 
RNA, which then can refold to a new conformation (Tompa and Csermely, 2004). To 
predict if p33 replication protein contains naturally disordered regions, I used 
PONDR VL-XT (Romero et al., 1997; Bracken et al., 2004; Romero et al., 2004). As 
shown in Fig. 4.7, the p33 replication proteins of five tombusviruses were predicted 
to contain their two RNA-binding sequences within naturally disordered regions. The 
conserved naturally disordered RNA-binding regions in the p33 replication proteins 
further support the model that p33 functions as RNA chaperone.    
Based on previous results that p33 can bind to the viral RNA in a cooperative 
fashion and it can also bind to dsRNA, albeit less efficiently then to ssRNA 
(Rajendran and Nagy, 2003), I suggest that partial coating of the RNA by p33 might 
help unwinding secondary structure or dsRNA form. Since p33 could not separate the 
dsRNA strands in the 621 bp long dsDI-72 RNA, I propose that p33 has a weak RNA 
chaperone activity, which might only be enough to open up dsRNA form from the 
end carrying the AU-rich stretch (within the plus-strand initiation promoter, Fig. 4.5) 
or the short silencer-promoter structure (Fig. 4.4C-D). Indeed, providing a weaker 
dsRNA structure in dsDI72 (5'm3-8) (Fig. 4.5D), which has a "bubble structure" 
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(Panavas et al., 2006), led to 5-fold enhanced RdRp activity by the TCV p88C due to 
the RNA chaperoning activity of p33. It is plausible that p88C is not efficient enough 
to bind to the dsRNA regions (i.e., leading to inefficient loading of the RdRp on the 
template). However, p33 might help opening up the dsRNA structure from the 
weaker AU-rich end, followed by loading the RdRp and then plus-strand synthesis 
(Fig. 4.8). Indeed, I have shown previously that both the CNV replicase and p88C 
can only open up the "left-side" of the dsRNA carrying the AU-rich stretch. Thus, 
our in vitro data indicate that the primary function of p33 as an RNA chaperone is to 
facilitate initiation of RNA synthesis by making the promoter regions accessible to 
the viral RdRp. Unwinding of additional internal RNA structures might be 
accomplished by the viral RdRp during RNA synthesis as demonstrated earlier 
(Panavas et al., 2006). Interestingly, binding of p33 or p33C to ssRNA regions 
actually inhibited RdRp activity (Fig. 4.5B, lanes 11-20 and Fig. 4.6C). This suggests 
that p33 and especially p33C bound strongly to the ssRNA might hinder RdRp 
activity. Based on this and other data, I propose that the RNA chaperone activity of 
p33 affects both plus- and minus-strand synthesis via facilitating initiation (Fig. 4.8). 
Future in vitro assembly approaches should help to address this and related questions.            
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Materials and Methods 
 
Preparation of dsRNA templates.  
 
 First, single-stranded (ss)RNA templates were obtained by in vitro transcription 
with T7 RNA polymerase using PCR amplified DNA templates (Panavas et al., 
2002; Panavas and Nagy, 2005). Second, to make the dsRNA constructs, I annealed 
the heat denatured ssRNA transcripts (94 0C for 5 min) in STE buffer (10 mM TRIS, 
pH 8.0, 1 mM EDTA, and 100 mM NaCl), followed by slow cooling (30 min) to 25 
0C (Panavas and Nagy, 2005; Panavas et al., 2006). The annealed RNAs were loaded 
onto 5% non-denaturing polyacrylamide gels, followed by staining with ethidium 
bromide. After cutting out the annealed RNA band, I eluted the dsRNA into 0.6 M 
ammonium acetate, followed by phenol/chloroform extraction and ethanol 
precipitation (Panavas et al., 2006). The quality of the obtained dsRNA was checked 
by nondenaturing polyacrylamide gels. 
 
Purification of recombinant proteins 
 
TCV p88C RdRp and CNV p33 were expressed as MBP-fusion proteins in E. 
coli and purified using affinity-based chromatography as described earlier (Rajendran 
et al., 2002; Rajendran and Nagy, 2003), except that 2µg RNase A was added to the 
sonicated cell lysate and incubated it for 15 min on ice to remove RNA. The protein 
concentrations were adjusted to 250 µg /ml with column buffer (Rajendran et al., 
2002; Rajendran and Nagy, 2003).  
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In vitro replicase assays  
 
TCV RdRp reactions were carried out for 2 h at 25°C in the RdRp buffer 
consisting of 50 mM Tris-HCl (pH 8.2), 10 mM MgCl2, 10 mM dithiothreitol, 100 
mM potassium glutamate, ATP, CTP, and GTP (1.0 mM each), and 0.3 µl of 
[32P]UTP  (0.1mCi/ml)  in  50 µl volume (Rajendran et al., 2002). Each RdRp 
reaction mixture contained 0.5µg template (ds or ssRNA), 1.5 µg purified p88C 
RdRp enzyme (Panavas et al., 2006) and p33. After phenol-chloroform extraction 
and ammonium acetate-isopropanol precipitation, the RNA products were treated 
with S1 nuclease followed by another phenol-chloroform extraction and ammonium 
acetate/isopropanol precipitation. The samples were analyzed by electrophoresis on 
denaturing 5% acrylamide, gels containing 8 M urea. The gels were dried, exposed to 
a phosphorscreen and analyzed using Typhoon phosphorimager (GE Healthcare) and 
ImageQuant software .  
 
RNA gel mobility shift assay 
 
RI(-)probe of DI-72 RNA was labeled with [32P]UTP using T7 RNA 
polymerase. Approximately 20 ng of labeled RNA was incubated with MBP-p33 
mutant for 20 min at room temperature in the RdRp buffer (Rajendran et al., 2002; 
Rajendran and Nagy, 2003). The samples were analyzed by electrophoresis on native 
5% acrylamide gels, run at 200 V for 20 min at 4°C in Tris-acetate-EDTA (TAE) 
buffer. Analysis was as described above.  
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S1 nuclease sensitivity assay  
 
The dsRNA was obtained using [32P]UTP-labeled (-)DI-72 RNA  and 
unlabelled (+)DI-72 RNA in STE buffer. Different amounts (0, 0.5, 1, and 2  µg) of 
recombinant CNV MBP-p33 mutants were added to the dsRNA (approximately 
15ng) in RdRp buffer in 10µl final volume. The samples were incubated for 15 
minutes at room temperature, then 85U of S1 nuclease were added in 1.2µl 10x S1 
buffer (Promega) followed by 15 minutes incubation at 37 °C. The samples were 
loaded on a non-denaturing 8% acrylamide gel containing 0.1% SDS.   
 
Strand separation (unwinding) assay  
 
Oligo #2610 (GGAAATTCTCCAGGA) was [32P]-labeled at the 5' end with 
γATP  (0.05 mCi) using polynucleotide kinase (Fermentas). The annealing of 4 pmol 
of oligo and 4 pmol of DI-72(-) RNA in STE buffer was done at 37 °C for 20 
minutes. Different amounts of MBP-p33 (0, 1, and 2µg) was added to the annealed 
ssDNA/ssRNA hybrid in the RdRp buffer, followed by incubation at room 
temperature for 20 minutes. The samples were then analyzed by electrophoresis on 
non-denaturing 8% acrylamide gels containing 0.1% SDS [modified from (Zuniga et 
al., 2007)].  
 
Ribozyme self-cleavage assay 
 
The satellite (-) ribozyme of TRSV (Buzayan et al., 1986) fused to the 3' end 
TBSV RIV RNA was made by T7 polymerase. The purified recombinant MBP-p33 
was included in the 20 µl T7 reaction. The DNA template for the T7 polymerase was 
obtained by PCR using oligos  
#19 (GTAATACGACTCACTATAGGAATTCCTGTTTACGAAAG) and #1069 
(CCGGTCGAGCTCTACCAGGTAATATACCACAACGTGTGT) with plasmid 
81 
 
pYC2/CT DI-72-Rz (Panavas and Nagy, 2003). Incubation was at 37 °C for 20 
minutes, followed by a phenol chloroform extraction and ethanol precipitation. The 
radioactively labeled RNA was loaded to a denaturing 5% acrylamide gel/8M urea.  
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Fig. 4.1 Unwinding of the ssDNA/ssRNA hybrid by p33 in a strand separation assay. 
(A) Scheme of the strand separation assay showing the hybridized ssDNA/ssRNA. 
The 5' end labeled, 16 base ssDNA was annealed to the unlabeled DI-72(-) RNA prior 
to the addition of purified recombinant p33. (B) Lane 1: free ssDNA plus 2 µg of 
purified MBP-p33; lane 2: annealed ssDNA/ssRNA, no p33; lane 3: annealed 
ssDNA/ssRNA plus 1 µg purified recombinant p33; lane 4: annealed ssDNA/ssRNA 
plus 2 µg p33. The 32P-labeled free ssDNA and ssDNA/ssRNA hybrid were separated 
on nondenaturing 10% acrylamide gels. The gel contained 0.1% SDS to dissociate 
protein-RNA complexes. Quantification was done with ImageQuant. (C) Ethidium-
bromide-stained denaturing PAGE to show the intact DI-72(-) RNA in samples 
treated as shown in legend B.  
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Fig. 4.2 Increased sensitivity of dsRNA to single-strand specific S1 nuclease due to 
the RNA chaperone activity of p33. (A) Schematic presentation of the dsDI-72 RNA 
template and the treatment applied. (B) Representative denaturing gel of radiolabeled 
RNA template (5 ng) that remained after the S1 nuclease treatment in the presence of 
0, 0.5, 1 and 2 mg of purified recombinant p33 are shown. The samples were 
phenol/chloroform extracted prior to gel-analysis. (C) A control experiment showing 
that dsRNA template is insensitive to treatment with purified p33 in the absence of 
S1 nuclease. The condition during the experiments is comparable to that shown in 
panel B, except S1 was not added to the samples. (D) A control experiment showing 
that dsRNA template is insensitive to treatment with S1 nuclease in the presence of a 
p33 mutant lacking the RPR RNA-binding sequence. See further details in panel B.       
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Fig. 4.3  Recombinant CNV p33 promotes the self cleavage activity of the satellite 
Tobacco ringspot virus ribozyme in vitro. (A) Schematic presentation of the RNA 
template carrying the ribozyme sequence before and after the self-cleavage. (B) 
Representative denaturing gel of 32P-labeled RNA cleavage products, which are 
derived from the template RNA synthesized by in vitro transcription with T7 RNA 
polymerase in the presence of 0, 1 and 2 mg of purified recombinant p33 are shown. 
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Fig. 4.4  Recombinant p33 promotes initiation on RNA templates by the RdRp. (A) 
Schematic presentation of the ssDNA/ssRNA hybrid template used to program the 
TCV p88C RdRp preparation in vitro. (B) Representative denaturing gel of 32P-
labeled RNA product synthesized by TCV p88C RdRp in vitro in the presence of 0, 1 
and 2 mg of purified recombinant p33 is shown. The level of RNA synthesis was 
compared to that of the RdRp activity obtained in the absence of ssDNA and p33 
(100%). The samples were treated with S1 nuclease to exclude terminal transferase-
based labeling of DI-72(-) RNA, which might be present in the affinity-purified TCV 
p88C or CNV p33 preparations. Each experiment was repeated three times. (C) 
Schematic presentation of the 3' terminus of the (+)DI-72 RNA template used to 
program p88C RdRp in vitro. The base-pairing interaction between the replication 
silencer (RSE) and the minus-strand initiation promoter (gPR) is indicated with a 
double-headed arrow. The site of initiation of complementary RNA synthesis is 
marked below the sequence. (D) Representative denaturing gels of radiolabeled RNA 
products synthesized by p88C RdRp in the presence of 0, 0.5, 1, 2 and 4 mg of 
purified p33 are shown. The samples were treated with S1 nuclease.  
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Fig.4.5 Recombinant CNV p33 promotes initiation on dsRNA template by the 
recombinant TCV RdRp. (A) Schematic presentation of the two dsRNA templates 
used to program the TCV p88C RdRp preparation in vitro. (B) Representative 
denaturing gels of 32P-labeled RNA products synthesized by in vitro transcription 
with TCV p88C RdRp in the presence of 0, 0.5, 1, 2 and 4 mg of purified 
recombinant p33 are shown. The dsRNA templates were gel isolated after annealing 
of plus- and minus-stranded RNAs (in 1:1 ratio), and they were used in equal 
amounts (0.5 mg per sample). The level of RNA synthesis was compared to that of 
the RdRp activity obtained in the absence of p33 (100%). The samples were treated 
with S1 nuclease to exclude terminal transferase-based labeling of dsDI-72, which 
might be present in the affinity-purified TCV p88C or CNV p33 preparations. Each 
experiment was repeated three times. (C) Representative denaturing gels of 
radiolabeled RNA products synthesized by in vitro transcription with TCV p88C 
RdRps in the presence of 0, 1 and 2 mg of a p33 mutant are shown. The p33 mutant 
lacked the RPR sequence involved in RNA binding. See Fig. 5B for further details. 
(D) Schematic presentation of the two RNA templates used to program the TCV 
p88C RdRp preparation in vitro. See Fig. 5A for further details. (E) Representative 
denaturing gels of radiolabeled RNA products synthesized by in vitro transcription 
with p88C RdRp in the presence of 0, 0.5, 1 and 2 mg of purified recombinant p33 
are shown. The samples were treated with S1 nuclease. See Fig. 5B for further 
details.  
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Fig. 4.6 The lack of RNA chaperone activity of p33 mutant missing the N-terminus 
in vitro. (A) Schematic presentation of CNV p33 and mutants with known functional 
domains. The only previously known function of the N-terminal sequence was its 
involvement in the localization of p33 to the peroxisomal membrane (including the 
trans-membrane domains, TMDs). The C-terminal sequence carries the Arginine-
proline-rich (RPR) domain involved in RNA binding and the S1 and S2 subdomains 
involved in p33:p33/p92 interaction. (B) Representative denaturing gels of 
radiolabeled RNA products synthesized by in vitro transcription with p88C RdRp in 
the presence of 0, 0.5, 1 and 2 mg of purified recombinant p33C are shown. The 
samples were treated with S1 nuclease. See Fig. 5B for further details. (D) Gel-
mobility shift assay that shows RNA binding by the truncated p33 variants. The 32P-
labeled probe (20 ng) was used with 0, 0.5, 1, 2, 4 and 8 mg of purified recombinant 
p33-N1-82 and p33-N1-72. The free RNA and the shifted band representing the 
RNA-protein complex are marked with arrows. The amount of free RNA left in the 
samples was quantified and shown as % of the total probe in the absence of protein 
(lanes 1 and 7). (E) Representative denaturing gels of 32P-labeled dsRI RNA template 
that remained after the S1 nuclease treatment in the presence of 0, 0.5, 1 and 2 mg of 
purified recombinant p33 mutant lacking the second RNA binding sequence are 
shown. The samples were phenol/chloroform extracted and precipitated prior to gel-
analysis. Note that I used a p33 mutant with increased solubility in E. coli due to the 
missing hydrophobic TMD domain. 
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Fig. 4.7 The RNA binding sequences are predicted to be present within intrinsically 
disordered (unstructured) regions in p33 replication proteins of five tombusviruses. 
The probability of disorder is shown graphically in p33 based on analysis with 
PONDR-VL-XT. Amino acids with disorder value (PONDR score) of more than 0.5 
are considered "disordered", whereas below 0.5 are considered "ordered". Arrows 
point at the two RNA-binding regions. 
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Fig. 4.8 A model on the possible role of the RNA chaperone activity of p33 in 
tombusvirus replication. I predict that p33 is involved in opening the closed silencer-
promoter structure, which then leads to minus-strand synthesis by the tombusvirus 
replicase (Step 1). Also, p33 might be involved in opening up the AU-rich terminus 
of the putative dsRNA intermediate (Step 2). I propose that binding of p33 to dsRNA 
could facilitate loading of the replicase to the open end, followed by initiation of 
plus-strand synthesis (bottom). It is likely that binding of p33 could stabilize the open 
structure within the AU-rich stretch in the cPR promoter as shown. After initiation, 
the tombusvirus replicase can efficiently unwind the remaining part of the dsRNA 
template during RNA synthesis as demonstrated earlier (Panavas et al., 2006). 
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CHAPTER  V 
 
Role of a host HSP70 protein in viral replication 
 
Introduction 
 
Viral replicases are the key enzymes in the replication of positive stranded 
RNA viruses. Replicase complexes are often associated with proteins from the host 
organism (Panavas and Nagy, 2003). For instance, the viral replicase complex 
consists of virus-encoded proteins, the RNA-dependent RNA polymerase (RdRp) and 
auxiliary viral protein(s), as well as a suite of host proteins and the viral RNA 
template (Serva and Nagy, 2006)). The replicase complexes are assembled on 
intracellular membranes, including the peroxisomal membrane in case of TBSV and 
CNV  (Panavas et al. 2005; Jonczyk, Nagy 2007). Recent studies have unveiled the 
role of a host protein in the peroxisomal localization of the viral replicase proteins 
((Jonczyk et al., 2007). However, in general little is known about the membrane 
translocation of viral proteins.  
 P33 and p92 the replication proteins of  the CNV  are membrane  proteins  
with the membrane spanning domain located between two hydrophilic regions. 
During the transport of the proteins through the cytosol the membrane spanning 
domain have to be in a conformation when it faces to the center of the protein 
transportation complex.  At the target membrane the membrane-spanning domain has 
to be inserted into the membrane.  No study was published about the mechanism of 
the membrane insertion of the proteins.   
Ssa1/2p were found to be associated with the viral repliacase complex. The 
overexpresion of Ssa1p enhanced, while the deletion of Ssa1and 2 decreased the 
RDRP activity in the yeast membrane fraction (Serva, Nagy 2006). These 
experiments indicated that Ssa1 and\or 2p are integral part of the viral replicase 
complex. Ssa is known to play a role in the translocation of precursor proteins into 
mitochondria and the ER  in an ATP dependent manner (Deshaies et al. 1988). 
 
 
97 
 
 Ssa is a member of the heat shock protein 70 family in yeast . The family 
consist of  four subfamily Ssa, Ssb, Ssc and Ssd. The Ssa subfamily has four members 
Ssa 1 and  2  is expressed constitutively while 3 and 4 is expressed from a heat 
inducible promoter (Werner  Craig 1987) 
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Results 
 
Ssa is needed for in vitro replicase activity 
 
 Recombinant p33 and p92 expressed in E. coli were not active in a previously 
developed in an in vitro RDRP assay (Rajendran and Nagy, 2003). However, if 
expressed in yeast, the co-purified CNV p33 and p92 showed in vitro RDRP activity 
(Panaviene Nagy 2003). To establish the mechanism rendering the replication 
proteins active in yeast, a novel system was developed using recombinant p33 and 
p92 expressed in E. coli and cell free yeast extract by Dr. Judit Pogany in our lab. In 
this cell-free assay, the recombinant viral proteins expressed in E. coli were able to 
replicate the viral template RNA. The membrane fraction of the yeast cell-free 
extract, however, was incapable of viral RNA synthesis in the presence of added 
recombinant p33 and p92 and the viral RNA template. Based on these data, I 
hypothesized that a yeast soluble (cytosolic) protein(s) is needed to form the active 
viral replicase complex in the cell-free extract. To identify the host protein involved 
in the assembly\activation of the replicase complex, I centrifuged the cell free yeast  
extract (15000 RPM for 10 minutes ) to divide  the membrane bound and soluble 
proteins. As expected, the membrane only (pellet) fraction showed reduced replicase 
activity compared to the combined membrane+soluble fractions.   
Since Ssa1p is part of the tombusvirus replicase complex (Serva and Nagy, 
2006), I wanted to test if the activator protein is the Ssa1p. For this test, I used the 
soluble fraction of Ssa1\2p deleted mutant yeast strain to rescue the replicase activity 
of the membrane fraction of the cell free extract. Yeast extract prepared from yeast 
carrying mutated, nonfunctional ssa1/ssa2 genes activated the replicase four fold less 
efficiently in vitro than the cell-free extract prepared from wild type yeast did (fig 
5.1). 
To further investigate the role of Ssa1/Ssa2p in activation of the tombusvirus 
replicase, I replaced the soluble fraction with various amounts of FLAG-tag affinity 
purified Ssa1p from yeast in an in vitro assay also containing the membrane fraction 
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of  the cell free extract in addition to p33/p92/repRNA. I found that the added purified 
recombinant Ssa1p was able to rescue the replicase activity in vitro. To find out 
whether the Ssa1p or a copurified protein  is responsible for the activation, I 
performed a high salt washing step to reduce the amount of co-purified yeast proteins 
in the Ssa1p preparation. Additionaly, an extra washing step was added to the assay 
with high (1.2 M NaCl) salt concentration aimed at removing additional proteins 
bound to the resin in a non-specific manner (via the peptide binding domain of 
Ssa1p). The high salt washing of Ssa1p did not reduce the replicase activity in the cell 
free extract assay (fig. 5.1). To further demonstrate that Ssa activated the E. coli 
expressed viral replicase proteins, I made two point mutations separately in the ATP 
binding socket of the Ssa1p, namely K69Q and G199D. These mutations inactivate 
the ATPase  activity of Ssa 1 p, rendering the protein defective (McClellan and 
Brodsky, 2000). Accordingly, both Ssa1p mutants were unable to activate the 
bacterial expressed viral replication proteins in the membrane fraction of the cell free 
extract. 
 
Ssa1/2p are needed for viral replication in yeast 
  
 Previous work showed that the deletion of ssa1/ssa2 significantly decreased 
the accumulation of viral replicon in yeast (Serva and Nagy, 2006). To further study 
the effect of ssa1/ssa2  deletion on viral replication, I used a temperature sensitive 
mutant Ssa1. While deletion of all four Ssa genes is lethal in yeast (Boorstein et al., 
1994), researchers constructed a yeast strain with  ssa2/ssa3/ssa4 deleted in 
combination with Ssa1 is a temperature sensitive allele (Becker et al., 1996). This 
strain was used to study the viral replication in the absence of SSA2/3/4 function. 
Transformation of the above temperature sensitive Ssa1 strain and wild type Ssa1 
strain with plasmids encoding the viral replicase proteins and DI72 repRNA regulated 
by galactose inducible promoters showed that the yeast strain expressing the 
temperature sensitive Ssa1p was not able accumulate detectable amount of viral RNA 
at the restrictive temperature. Meanwhile, the same strain at the permissive 
temperatue and the control strain expressing wild type Ssa1p accumulated viral 
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repRNA efficiently (Fig. 5.2).  The expression of the viral protein demonstrated by 
western blot analysis was as high in the nonpremissive versus permissive 
temperatures, suggesting that the defect at nonpermissive tepmerature is not due to 
the lack of expressed p33.   
There are several steps in viral replication, which could be affected by Ssa1p.  
To determine whether Ssa1p is involved in the early or the late steps, I induced the 
viral replication at the permissive temperature for six hours, and than changed the 
media to glucose to shut down the expression of viral proteins and repRNA. At the 
same time, I raised the temperature to the nonpermissive to inhibit the tsSsa1p 
function. After 18 hours, examination of the viral repRNA  accumulation  by northern 
blot showed that both the temperature sensitive and wild type Ssa1p  containing strain 
were able to accumulate viral RNA to a comparable levels at the permissive 
temperature (fig 5.2). This suggested that the viral proteins and replicon in the 
temperature sensitive and wild type Ssa1p bearing strains at permissive temperature 
allowed the viral replicase complex to assemble and start replication. On the contrary, 
we found no TBSV repRNA accumulation at the nonpremissive temperature in yeast 
expressing tsSsa1p (Fig. 5.3). Purifiation of the membrane fraction from these strains 
showed that the in vitro RDRP activity at the permissive 25 °C and non-permissive 
37 °C temperature were comparable (fig 5.3). 
 
 
Ssa is needed for the membrane localization of p92 and p33  
 
 p33 is localized in the cytosol  in the absence of  Ssa function (Robert  Wang 
unpublished data). To find out whether Ssa is needed for the viral proteins to be 
membrane bound a flag purified recombinant Ssa expressed in yeast, MBP fusion p33 
and p92 expressed in E. coli and cell free yeast extract. I collected the membrane 
fraction from the cell free yeast extract by centrifugation, washed it to obtain HSP 70 
free yeast membrane. To the membrane I added the purified Ssa and viral proteins 
together with ATP  incubated the reaction for two hours than collected the membrane 
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fraction. After washing three times to remove the water soluble proteins I studied the 
membrane fraction by western blot.  
 There were significantly more  viral proteins membrane bound in the samples 
with Ssa and ATP added than in the samples without Ssa,  ATP or with mutant K69Q 
and G199D Ssa. 
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Discussion 
 
 Earlier work revealed that Ssa1\Ssa2  yeast HSP70s are associated with the 
viral replicase complex (Serva and Nagy, 2006). Pull down experiments showed that 
Ssa binds to p33 in vitro. The deletion of the Ssa1/2 inhibited, overexpression of 
Ssa1\Ssa2 enhanced viral replication. These experiments established that Ssa plays a 
crucial role in viral replication in yeast, but the mode of action remained unclear. 
Since the deletion of all four Ssa results in lethality, a temperature sensitive Ssa1 
allele was developed to study Ssa in a ssa2-3-4 deletion background. The aim was to 
determine whether Ssa function is necessary for viral replication in yeast. Induction 
of viral protein expression at non-permissive temperature did not result  in detectable 
viral RNA accumulation. In contrast, the replication was not inhibited in vivo at non-
permissive temperature if the viral replication proteins were expressed at permissive 
temperature. The in vitro results too showed no significant difference in RDRP 
activity at permissive and non-permissive temperature, if the viral replication proteins 
were expressed at permissive temperature.  These results suggested that Ssa plays a 
role in the early steps of viral replication.  
Laser scanning confocal microscopy experiments showed that the misslocalization of 
viral proteins were consistent with the lack of Ssa function. 
 P33  was cytosolic at non-permissive temperature if expressed in ts Ssa1, ssa2, 
ssa3, ssa4 yeast (Robert Wang unpublished data). Published data demonstrates that 
Ssa facilitates transporting membrane proteins through the cytoplasm. Ssa binds to 
the hydrophobic regions of the proteins keeping them in soluble form and preventing 
coagulation and precipitation of the highly hydrophobic proteins. This way the 
membrane proteins can be transported from the site of translation to the target 
membrane (Boorstein et al., 1994). Tombusviruses utilize the peroxisomal membrane 
to form a “pocket” where the replication takes place. Our confocal microscopy data 
showed that the viral replication protein does not target the peroxisomal membrane 
without Ssa function (Robert Wang unpublished data). Rather, the protein distribution 
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observed as fluorescence was seen evenly throughout the cytosol. The “doughnut 
shape” localization of the protein shows that it is in a soluble form, even if it has long 
highly hydrophobic regions. Our earlier data showed that p33 precipitates if 
expressed in bacteria-which lacks the Ssa proteins-with his tag (Judit Pogany 
unpublished data). The solubility of p33 in the temperature sensitive mutant at non 
permissive temperature suggests that the interaction between p33 and tm Ssa  is not 
disrupted by the Ssa mutation. The point mutation, which makes Ssa temperature 
sensitive, is in the ATP binding domain of the protein. Since the peptide-binding 
domain is not affected Ssa can bind to p33 keeping it in soluble form. This suggests 
that the proper localization of p33 requires the ATPase activity of Ssa. Previous work 
demonstrated that Ssa stimulates the post-translational translocation of wheat-germ-
translated PPαf into microsomes (Chirico et al., 1988).  
Examination of the membrane localization of viral proteins in presence and 
absence of Ssa and/or ATP showed that when both Ssa and ATP were present, there 
was approximately a four-fold increase in membrane bound p33  compared to the 
reactions when either ATP or Ssa was not added to the reaction mixture. Based on 
this result and in combination with the findings of Chirico , the most plausible 
explanation is that Ssa functions as a molecular ratchet pulling the hydrophilic portion 
of p33/92 through the membrane. Alternatively, as yet unknown proteins are 
interacting with Ssa are key to the replication process. Results stemming from these 
experiments establish that Ssa is needed for the activation of recombinant p33 
purified from E. coli. In vitro studies showed that recombinant p92 and p33 
expressed as an MBP-fusion protein in E. coli have no RDRP activity, if expressed in 
baker’s yeast  with his tag  have RDRP activity. In this case the main difference 
between the bacterial and yeast expression is the lack of the peroxisomal membrane 
and Ssa function in the bacteria. The peroxisomal membrane serve as a platform to 
assemble the tombusvirus replicase complex (Jonczyk et al., 2007), and Ssa is needed 
for the membrane insertion of the replicase protein. 
Based on this results I propose a model: Ssa p  binds to the hydrophobic 
portions p33/92 at the ribosome, keeping them in soluble form  during the transport to 
the peroxisomal membrane where  it inserts them into the membrane in an ATP 
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dependent manner. The membrane insertion renders the proteins functional. This way 
the replication takes place only inside the membrane structure formed by the replicase 
complex, and not in the cytosol where the double-stranded viral RNA would be 
exposed to the plant defense system activating the PTGS. 
 
Materials and methods 
Yeast strains 
 Saccharomyces cereviseae strain InvSc1 (Invitrogen) was used as the wild 
type (wt), The double deletion (ssa1 ssa2) strain MW123 (his3 leu2 lys2 trp1 ura3 
ssa1::HIS3 ssa2::LEU2; (Wernerwashburne et al., 1987)), the temperature sensitive 
mutant a1-45 (ssa1ts ssa2 ssa3 ssa4)  and its wild type (SSA1 ssa2 ssa3 ssa4) (Becker 
et al., 1996) was kindly provided by Elizabeth A. Craig. 
 
Plasmid constructs  
 
 To express the viral replicase proteins and DI-72, I used pGBK -p33, pGAD-
his-p92, pYES-DI-72 plasmids (Panaviene et al., 2004)). For the dual expression of 
p33 and Di-72 from a single plasmid, I used the plasmid pESC-His-p33-DI-72 
(Jonczyk et al., 2007)that use the galactose inducible GAL1 and GAL10. For 
overexpression of Flag-tagged Ssa1p, I used the plasmid  pYC-HFSSA (Serva Nagy 
2006) carrying GAL1 promoter. Two mutants of Ssa1, namely K69Q and ssa1-103 
(G199D), were obtained using the Quick-Change site-directed mutagenesis kit 
(Stratagene). For obtaining K69Q, I used the primer pair of 5'-
CCGTTTTCGACGCTCAGCGTTTGATCGG-3' and 5'-
CCGATCAAACGCTGAGCGTCGAAAACGG-3', for G199D: 5'-
GATTTTCGACTTGGGTGATGG TACTTTC GATGTC-3' and 5'-
GACATCGAAAGTACCATCACCCAAGTC GAAAATC-3' (McClellan and 
Brodsky, 2000). 
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RNA blot analysis of total RNA from yeast cells 
 
 Total RNA extraction from yeast was performed as described earlier (Panavas 
and Nagy, 2003). Briefly, equal volumes of buffer (50 mM sodium acetate [pH 5.2], 
10 mM EDTA, 1% SDS) and water-saturated phenol were added to the yeast cells 
pelleted by centrifugation and resuspended by vortexing. After incubation for 4 min 
at 65°C, and for 2 min on ice, the samples were centrifuged at 21,000 x g for 5 min at 
room temperature (RT). The total RNA was precipitated by adding 2 volumes of 95% 
ethanol to the aqueous phase, followed by centrifugation at 21,000 x g for 15 min at 4 
ºC. The pelleted RNA samples were washed with 70% ethanol, dried and dissolved in 
Tris-EDTA buffer (50 mM) and formamide (in 1:1 ratio). The samples were heated 
for 5 min at 85°C, electrophoresed in 1% agarose gels, and transferred to Hybond XL 
membrane (Amersham), and cross-linked to the membrane using UV (Bio-Rad). 
Hybridization to the 32P-labeled RNA probe was done in ULTRAhyb solution 
(Ambion) at 68°C according to the supplier's instructions. The  32P--labeled 
complementary DI-72 RNA probe was  obtained via T-7 transcription. 
 
Western blot analysis 
 
 For total protein extract from yeast I harvested yeast cells by centrifugation 
from 1 ml culture, the cell were dissolved in 0.2 ml 100 mM NaOH and vortexed for 
5 minutes. The samples were centrifuged for 2 minutes at 21000 g and the NaOH 
solution was carefully removed, 0.2ml SDS-PAGE sample loading buffer (Sambrook 
et al. 1989) was added to the protein samples, followed by  heating for 5 min at 85°C, 
electrophoresis in SDS-8% PAGE gels, and electro-transfer to a polyvinylidene 
difluoride membrane (Bio-Rad). The membrane was incubated in 5% nonfat dry milk 
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solution in Tris-buffered saline (TBS) buffer (Sambrook et al. 1989) containing 0.1% 
Tween 20 (TTBS) for one hour to avoid nonspecific binding of antibodies.  The 
membrane was washed three times with TTBS buffer and incubated with monoclonal 
anti-His antibodies (Amersham) for 1 h at room temperature, washed again three 
times for 10 min with TTBS buffer, and then  the membrane was incubated for 1 h at 
room temperature with secondary antibody (alkaline phosphatase-conjugated, Sigma). 
After three 10 min washes with TTBS, proteins on the membrane were visualized 
using 5-bromo-4-chloro-3-indolylphosphate and nitroblue tetrazolium (Sigma). 
 
In vitro replication assays using cell free yeast extract 
 
 The cell free yeast extract for the replication assay was obtained as published 
earlier (Pogany, Nagy 2008). Briefly: the selected yeast strains were grown in 200 ml 
glucose media until reaching ~OD=1, than harvested by centrifugation at 4000 rpm 
for 4 min at 4°C. The pellet was washed twice with water and twice with buffer A 
(0.3 ml of 1 M HEPES-KOH pH 7.4, 1 ml of 1 M potassium acetate, and 0.02 ml of 
1M magnesium acetate). Then, 0.5 g of pellet was suspended in 0.75 ml buffer A 
containing 1.5 µl 1M DTT and 3 g pre-chilled glass beads. The yeast cells were 
broken by shaking for 5 min, followed by centrifugation at 500 x g at 4 ºC for 5 min 
in a swinging bucket rotor. The supernatant was then moved to a new tube, followed 
by centrifugation at 500 x g at 4 ºC for 5 min. The supernatant was stored at -80C 
until use. The above yeast cell-free extract (1 µl) was pre- incubated on ice for 10 min 
in 10 µl cell-free replication (CFR) buffer containing [50 mM  HEPES-KOH pH 7.4, 
150 mM potassium acetate, 5 mM magnesium acetate, 0.2 M sorbitol and 0.4 µl 
Actinomycin D (5 mg/ml)]. Then, the reaction volume was adjusted to 20 µl with 1x 
CFR buffer also containing 2 µl of 150 mM creatine phosphate, 2 µl of 10 mM ATP, 
CTP, GTP and 0.25 mM UTP, 0.3 µl of 32P-UTP, 0.2 µl of 10 mg/ml creatine kinase, 
0.2 µl of RNase inhibitor, 0.2 µl of 1 M DTT, and 0.5 µg RNA transcript. The 
reaction was incubated at 25 ºC  for 3 hours. The reaction was terminated by adding 
110 µl   stop buffer (1% SDS and 0.05M EDTA pH 8.0), followed by 
phenol/chloroform extraction, isopropanol/ammonium acetate precipitation, a 
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washing step with 70% ethanol as described earlier ( Nagy et al.  2000). For testing 
the replicase activity in the membrane-enriched fraction from yeast extract, we 
centrifuged the cell-free extract for 10 min at 21,000 x g at 4 ºC to separate the 
membrane-enriched and soluble fractions. The membrane-enriched fraction dissolved 
in buffer A was used in the in vitro replication assays with the addition of the soluble 
fraction of the appropriate yeast strains or affinity (Flag-tag) purified recombinant 
proteins (Ssa1p or mutant Ssa1p) expressed in yeast. 
 
Flag-tag purification  
 
 For expression of Flag-tagged Ssa1p, I used plasmid pYC-HFSSA (Serva and 
Nagy, 2006)). To express the Ssa1p without a tag, I used pYES2/NT-Ssa, which was 
obtained by cloning the SSA1 sequence into pYES2/NT plasmid between the 
restriction sites Hind III and Xho I. I then PCR- amplified the SSA1 sequence using 
the primer pair of 5'-GGC AAG CTT ATG TCT AAA GCT GTC GGT ATT, and 5'-
GGC CTC GAG TTA  ATC AAC TTC TTC GAC AGT. To express the viral 
replicase protein p92, I used pGAD-His92 plasmid (Panaviene et al., 2004). 
Saccharomyces cerevisiae strain InvSc1 (Invitrogen) was used for expression of the 
recombinant proteins.  Yeast was co-transformed with plasmids pYC-HFSSA, 
pGAD-His92, pESC-His-p33-DI-72 and pYES2/NT-Ssa, pGAD-His92, pESC-His-
p33-DI-72. The yeast was grown in 10ml SC-ULH 2% glucose medium for 24 hours, 
and the cells were harvested by centrifugation at 100 × g for 5 min, washed and 
resuspended in 200ml SC–ULH 2% galactose medium. The yeast culture was then 
grown until reaching OD 0.8 (approximately 8 hours) at 23 °C.  
Cells were harvested by centrifugation and the membrane proteins were 
obtained as described earlier (Panaviene et al., 2004)). Briefly, yeast cells were 
ground in a mortar in liquid nitrogen. The obtained 1 volume yeast powder was 
dissolved in ten-volume extraction buffer (200 mM sorbitol, 50 mM Tris-HCl [pH 
7.5], 15 mM MgCl2, 10 mM KCl, 10 mM β-mercaptoethanol, yeast protease inhibitor 
mix; Sigma). Cell debris was removed by centrifugation at 100 × g for 1.5 min at 
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4°C. Membrane fraction was obtained from the extract by centrifugation at 21,000 × 
g for 15 min at 4°C.  
The enriched membrane fraction was resuspended in 500 µl extraction buffer 
containing 1% Triton X-100 by gentle rotation for 1 h at 4°C, followed by 
centrifugation at 21,000 × g for 15 min at 4°C. 30 µl anti-FLAG M2-agarose affinity 
gel (Sigma) was added to supernatant and rotated for 1 h at 4°C. The FLAG resin was 
washed twice with 1ml RDRP buffer (50 mM Tris-HCl (pH 8.2), 10 mM MgCl2, 10 
mM dithiothreitol, 100 mM potassium glutamate), then eluted with 100µl RDRP 
buffer containing 5µg/ml FLAG peptide. 25µl of the eluted proteins were added to 
the in vitro replication assay. The in vitro replication assay was performed at 25 °C 
for two hours. I used 0.5 µg of external/added RNA templates for the 50 µl reactions 
(Nagy and Pogany, 2000)). The RdRp products were phenol-chloroform extracted 
and loaded on denaturing PAGE gel (i.e., 5% PAGE containing 8 M urea). Then the 
gels were dried and exposed to phosphorscreen and evaluated with Typhoon imager 
and Imagequant software.  
 
In vitro replication assays based on recombinant viral proteins expressed in yeast 
 
 For this replication assay, I obtained the membrane fraction from yeast as it is 
described in the FLAG-tag-based purification method above, with the difference that 
I added 5% SB3-10 (caprylyl sulfobetaine) to the extraction buffer. The obtained 
membrane fraction was considered enriched membrane fraction, which was 
resuspended in the extraction buffer and used in the in vitro replicase reactions as it is 
described below. 
To affinity purify the CNV replicase preparation from yeast, the enriched 
membrane fraction was resuspended in the extraction buffer containing 1.2 M NaCl, 
followed by gentle rotation for 20 min at 4°C and centrifugation at 21,000 x g for 15 
min at 4°C. The obtained pellet was resuspended in the extraction buffer containing 
1% Triton X-100 and 5% SB3-10 (caprylyl sulfobetaine) (Sigma) by gentle rotation 
for 1 h at 4°C, followed by centrifugation at 21,000 x g for 15 min at 4°C. The 
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obtained supernatant was considered the solubilized membrane fraction. This 
preparation was tested in the in vitro replicase assay as described below. 
 To prepare the samples for the 6xHis tag-based metal affinity purification, the 
solubilized the enriched membrane fraction in the solubilization buffer (extraction 
buffer plus 1% Triton X-100, 5% SB3-10, and 0.5 M KCl) was centrifuged to remove 
insoluble materials, and then the supernatant was applied to a column containing 
ProBond resin (Invitrogen) equilibrated with the solubilization buffer. The column 
was then rotated for 1 h, followed by washing with two column volumes of the 
solubilization buffer, washing with the extraction buffer containing 1% Triton X-100 
and 5% SB3-10, and then a second wash with the extraction buffer containing 1% 
Triton-100, 5% SB3-10, and 2 mM imidazole. The recombinant proteins were 
recovered from the column in the extraction buffer containing 150 mM imidazole, 1% 
SB3-10, and 0.1% Triton X-100 in a two-step elution (each in a half-column volume). 
The purity of the obtained recombinant protein-containing preparations was tested by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (51, 57), while the amount 
of the recombinant proteins in various samples was compared by using Western 
blotting with monoclonal anti-His tag antibody (GE Healthcare). 
 
Purification of  p33 and p92 proteins from E. coli.  
 
 The expression and purification of the recombinant TBSV proteins were 
carried out as described (Rajendran and Nagy, 2003). Briefly, protein expression 
plasmids were transformed into Epicurion BL21-CodonPlus (DE3)-RIL (Stratagene). 
The overnight cultures from the transformed bacterial cells were diluted to 1:100 in 
rich growth medium (10 g of tryptone, 5 g of yeast extract, 5 g of NaCl) containing 
0.2% glucose and 100 µg of ampicillin per ml and grown at 37°C until the optical 
density reached 0.6 to 0.8. Protein expression was then induced at 14°C with 0.3 mM 
IPTG (isopropyl-ß-D-thiogalactopyranoside) for 8 to 10 h. The induced cells were 
harvested at 4,000 x g at 4°C for 10 min, resuspended in ice-cold column buffer (10 
mM Tris-HCl [pH 7.4], 1 mM EDTA, 25 mM NaCl, 10 mM ß-mercaptoethanol), 
sonicated on ice to disrupt the cells, and centrifuged at 21,000 x g  for 10 min at 4°C. 
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The supernatant was added to an equilibrated amylose resin column (New England 
Biosciences), washed thoroughly with 20 volumes of column buffer, and eluted with 
10 mM maltose in column buffer. All protein purification steps were carried out at 
4°C. The purified recombinant proteins were analyzed in SDS-8% polyacrylamide gel 
electrophoresis (SDS-PAGE) for their purity. The protein concentrations were then 
adjusted to 250 µg/ml using the Bradford assay. 
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Fig 5.1 RDRP activity of yeast cell free extract membrane fraction with added MBP p33 
and p92  
A.) lanes 1-3 WT yeast  
lanes 4-6 ssa1,ssa2,Ssa3,Ssa4 yeast strain 
 
B.) lanes 1-3 FLAG-tag affinity purified Ssa1 protein  in increasing concentration  
lane 4 FLAG resin purified yeast extract  
lane 5 Ssa protein  
lane 6 yeast membrane without SSa 
lane 7 yeast membrane with the soluble fraction of the yeast 
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Fig 5.2 Effect of high concentration (1.2 M) salt washing during affinity purification of 
Flag tagged Ssa1 p on RDRP activity of yeast cell free extract membrane fraction with 
added MBP p33 and p92  
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Fig 5.3  RDRP activity of yeast cell free extract membrane fraction with added mutant 
and wt Ssa1 p 
A.) lane 1 Flag tag affinity purified Ssa1  
lane 2 Soluble fraction of the yeast cell free extract   
lane 3 Flag tag affinity purified K69Q mutated Ssa 1 P  
lane 4 Flag tag affinity purified G199D mutated Ssa 1 P 
B.) Western blot analysis of  Flag tag affinity purified wt and mutated Ssa1p used 
in the assay   
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Fig 5.4 RDRP activity of membrane enriched fractions obtained from wt Ssa 1 ssa 2, 3, 4  
and ts Ssa 1 ssa 2, 3, 4   yeast strains grown at permissive temperature. 
RDRP reactions were performed at 25° C and 37° C using yeast membrane enriched 
fractions obtained from wt Ssa 1 ssa 2, 3, 4  and ts Ssa 1 ssa 2, 3, 4 (the yeast cells were 
grown at 23° C )   
  lanes 1,2 wt Ssa  at 25° C; 
lanes 3,4  ts Ssa 25° C; 
lanes 5,6 wt Ssa  at 37° C; 
lanes 7,8 ts Ssa at 37° 
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temperature 
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Fig 5.5  Northern blot analysis of  the replicon RNA  isolated from wt Ssa 1 ssa 2, 3, 4  
and ts Ssa 1, ssa 2, ssa 3, ssa 4   yeast strains grown at different temperatures. 
A. Yeast strains were  pre-grown in media containing glucose at  permissive  
temperature, than shifted the temperature to the non- permissive 36°C, and at 
the same time changed the media to induce the expression viral replication 
proteins and replicon. After 18 hours of induction RNA was  isolated from the 
yeast cells examined by northern blot 
B.  Replication was induced at the permissive temperature for six hours, than the 
media was changed to glucose to shut down the expression of viral proteins 
and replicon. At the same time the temperature was raised to the non 
permissive to kill he Ssa function,  after 18 hours the viral RNA  accumulation 
was examined  by northern blot. 
 
C. Western blot analysis of p33 protein expression during assay A 
 
p33 
 
A 
Temperature sensitive Ssa1                    wt Ssa1 
Protein expression  
B 
RNA accumulation 
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Fig 5.6 Western blot analysis of membrane fractions of yeast cell free extract membranes  
incubated with  
1.) the soluble fraction of the yeast cell free extract 
2.) Flag tag affinity purified Ssa 1 p and ATP 
3.) ATP only 
4.) Flag tag affinity purified Ssa 1 p only  
5.) RDRP buffer with no ATP or Ssa 1P 
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CHAPTER VI 
 
 
Summary 
 
 
 The tombusvirus p33 is a multifunctional replication protein that is essential for 
the viral replication (Panaviene et al., 2004). The read through product of p33, namely 
p92 replication protein, contains the RDRP motif essential for RNA polymerization. At 
the beginning of my thesis work, the roles/functions of p33 replication co-factor during 
the viral replication process were unclear. During the course of my studies our lab have 
discovered several functions of p33 , such as RNA binding (Rajendran 2003) , 
recruitment of the viral RNA (Pogany 2005), assembly of the viral replicase complex 
(Panaviene et al., 2004, 2005).  
 My work on p33 focused on the area of posttranslational modification 
(phosphorylation) of p33, the RNA chaperone-like activity of p33, and its interaction 
with the heat shock protein 70 (Ssa1p, a yeast homolog). The results of the 
phosphorylation chapters suggest the significance of a phosphorylation sites in the 
vicinity of the RNA binding domain. The phosphorylation of these sites results in 
reduced RNA binding. Sequence comparison with other related viruses showed predicted 
phosphorylation sites at approximately the same positon. The presence of a conserved 
phosphorylation sites suggests that the phosphorylation-unphosphorylation cycle of 
serine, threonine residues in the vicinity of the RNA binding domain plays a major role in 
positive strand RNA virus life cycle. Phosphorylation sites are predicted in the vicinity of 
the arginin rich domain of the HIV Tat protein too by Netphos phosphorylation 
prediction program, suggesting that other viruses may use phosphorylation to reversibly 
disrupt RNA binding.  
My results suggest that p33 act as a weak RNA chaperone. Positive strand RNA 
virus replication produces approximately 100 more positive strand RNA than negative 
strand RNA. During the replication the newly synthetized positive strand RNA has to be 
removed from the negative strand, in order to make the negative strand available as a 
template. Although the TCV replicase can unwind double stranded structures, it requires 
the promoter to be single stranded. P33 facilitated the initiation of TCV replicase on fully 
double stranded RNA templates, suggesting that by binding to the double stranded RNA 
it can de-stabilize the double stranded structure exposing the promoter to the replicase. 
My work with the host factor Ssa showed that the Ssa1 and\or Ssa2 protein plays 
a role in p33 transportation through the cytoplasm to the target membrane and also 
facilitates the membrane translocation of the p33 protein. Other viruses might use heat 
shock proteins for similar function.    
 My contribution to the better understanding of the role p33 plays in the replication 
can be summarized in a single model. After translation, p33 is transported to the 
peroxisomal membrane by Pex19p host protein (Pathak et al, 2008). During the 
intracellular transportation of p33, the host HSP70 binds and covers the highly 
hydrophobic regions of the p33 protein. The interaction between the host HSP70 and p33 
renders the protein complex hydrophilic, thus preventing the formation of p33 aggregates 
and promoting the transport from the cytoplasm to the peroxisome membranes. At the 
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destination the host HSP70 facilitates the membrane integration of p33 in an ATP-
dependent manner. The integration of p33 into the membrane contributes to the proper 
folding of p33, with its C and N terminal ends carrying the RNA binding site and the 
protein interaction domains exposed towards the cytosolic surface of the membrane. 
This conformation is the “active” form of p33. Acting like a pair of pliers p33 facilitates 
the proper folding of the viral RNA for replication by weakening the RNA-RNA 
interaction between the silencer and the genomic promoter elements, thus facilitating the 
initiation of replication by the viral replicase complex.  
 After the new RNA is synthesized, a series of phosphorylation sites adjacent to 
the central RNA binding site are getting phosphorylated that weakens the RNA - p33 
interactions. This facilitates the release of the newly synthesized viral (+)RNA from the 
viral replicase complex.  
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Future directions 
 
 
 In all three area of my research there are unanswered questions: 
The plant kinase, which phosphorylates p33, is currently unknown. The yeast genome 
wide screen identified kinases, which alters the accumulation of viral RNA. Examining 
their plant analogs might lead to the identification of the host kinase(s), which 
phosphorylates the p33 in the native plants. 
 Another possible approach to identify the kinase(s) would be the chemical 
inhibition of the different kinase families, and examine the ability of the plant extract to 
phosphorylate the p33 at the predicted phosphorylation sites. This way we can narrow 
down the search to a distinct group of kinases.  
 Finding the cellular localization of the kinase would be another way which can 
lead to the identification of the kinase(s). Using ultracentrifugation techniques we can 
separate plant cell organelles and make protein preparations from them which can be 
tested in the in vitro phosphorylation experiments. 
 I focused my research on only two phosphorylation sites adjacent to the RNA 
binding motif of p33, but  there are other phosphorylation sites predicted in the protein by 
the NetPhos prediction program. Examining the possible role of them may lead the better 
understanding of the viral replication process. 
 The experiments to demonstrate the RNA chaperone activity of the p33 showed 
weak chaperone activity. Taking advantage of the new tools developed since the original 
experiments were made (yeast cell free extract, MBP fusion protein replication system) 
one can develop an experimental system to show stronger evidence. At the time I did the 
experiments we did not have a recombinant CNV replicase system. The CNV replicase 
we had was purified from infected plants and obviously we did not have a way to adjust 
p33-p92 ratio like we did in the recombinant TCV replicase system. Since then we 
developed a yeast membrane based system adding recombinant MBP fusion p92 and p33 
expressed in E. coli. 
 Using the new system one can adjust the p92-p33 ratio, and examine the effects 
on the RDRP activity. The new experimental system can show stronger evidence than the 
heterologus TCV replicase-CNV p33 system. 
 Dissecting the role of HSP70 family proteins, in plant-virus interactions is 
important. I showed the importance of ayeast HSP70 in viral replication in vitro. The 
observation that Ssa is part of the viral replicase complex suggests that Ssa plays other 
roles during the replication. HSP 70-s usually makes short term interactions with the 
target proteins, and after re-folding them search for new substrate. The functions of Ssa I 
demonstrated in the fifth chapter require short term interactions. The fact that Ssa co-
purifies with the viral replicase complex suggests that Ssa plays other roles during the 
replication, which require long term interaction.    Identifying the host HSP70 proteins in 
plants, which play a role in viral replication is important, not just for the better 
understanding of the virus-host interactions, but for chemical and/or biological inhibition 
of the host HSP70 functions. I think that this approach could lead to the discovery of 
novel antiviral drugs or other antiviral approaches. 
 
Copyright  2009 Jozsef Stork 
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